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[57] ABSTRACT 
New electron transfer moiety labeled nucleic acid analogue 
probes are provided that can be used in methods for deter-
mining nucleic acids in a sample. The new probes can be 
prepared using novel monomer subunits in a chemical 
synthesis route. The nucleic acids can be determined by 
binding the probe molecules to the nucleic acid and inducing 
electron transfer within the complex formed. The occurrence 
of the electron transfer is determined as a measure of the 
nucleic acid. 
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The invention of this application was conceived with 
support from the United States Government, and specifically 5 
the National Institutes of Health. 
redox components were intercalated (Brun, A. M.; 
Harriman, A J. Am. Chem. Soc. 1992, 114, 3656). Multi-
exponential electron transfer kinetics were attributed to 
Do-Ac separations of 3, 4, and 5 base pairs. The ~ value 
derived in that study (0.88 A-1 ) is comparable to that 
determined for Do-Ac systems in proteins, where stacked 
it-electron systems are not available for mediating electron 
transfer. Barton, Barbara and co-workers studied transition 
metal complex donors and acceptors which are intercalated 
FIELD OF THE INVENTION 
The present invention is directed to methods for deter-
mining a nucleic acid in a sample with a probe molecule 
using electron transfer from an electron donor to an electron 
acceptor. The invention is further directed to compounds 
useful in such methods and to compounds useful for the 
preparation of the probe molecules. 
BACKGROUND OF THE INVENTION 
Determinations of nucleic acids is becoming increasingly 
important as a tool for diagnosis in the health fields. For 
example, the presence of nucleic acids from organisms, like 
viruses, usually not present in the human body, can be 
determined using probes for the infecting nucleic acids. 
Further, any changes in the genome which may have a 
potential influence on the metabolism and the state of health 
of the individual can be determined. Such changes may have 
occurred by mutation or other means. Nucleic acid deter-
mination has made further progress with the introduction of 
nucleic acid amplification procedures, like the polymerase 
chain reaction (PCR). 
10 
into DNA and found that quenching of the donor fluores-
cence as well as recovery of the ground state absorption 
proceeds at rates which are independent of the number of 
bound acceptors, suggesting a very shallow distance depen-
dence for electron transfer through the DNA duplex (~<0.2 
15 
A.-1) (Arkin, M. R.; Stemp, E. D. A; Holmlin, R. E.; Barton, 
J. K.; Hormann, A; Olson, E. J. C.; Barbara, P. F. Science 
1996, 273, 475). However, cooperative binding of the donor 
and acceptor molecules, which would account for the 
loading-independent kinetics, could not be completely ruled 
20 out in that system. 
One of the problems associated with the use of non-
covalently bound donor and acceptor molecules in these 
studies is the inability to control precisely the location of the 
redox components relative to one another when they are 
25 bound to the DNA. In one extreme, the intercalation loca-
tions will be controlled statistically, leading to a distribution 
of Do-Ac separation distances. At another extreme, binding 
will be cooperative, leading to short distances between Do 
and Ac over a wide range of concentrations. 
Covalent linkage of Do and Ac to the 5'-ends of comple-
mentary oligonucleotides has led to systems with better 
defined Do-Ac separation distances . Barton, Turro and 
co-workers reported fluorescence quenching that occurs in 
less than one nanosecond for a system containing linked Do 
35 and Ac metal complexes intercalated near the ends of a 15 
base pair duplex (Murphy, C. J.; Arkin, M. R.; Jenkins, Y.; 
Ghatlia, N. D.; Bossmann, S.; Turro, N. J.; Barton, J. K. 
Science 1993, 262, 1025). A rate this fast indicates that the 
distance dependence of electron transfer through DNA is 
The presently known nucleic acid assays can be divided 30 
into two types, the heterogeneous and the homogeneous 
assays. In heterogeneous assays, the nucleic acid is deter-
mined by binding to a nucleic acid probe which is labeled for 
detection or by incorporation of labeled mononucleoside 
triphosphates and subsequent immobilization of the 
so-labeled nucleic acid to a solid phase. This is preferably 
done by using a solid phase bound capture probe, a format 
which provides the advantage that any excess amount of 
labeled probes or mononucleotides can easily be separated 
from the solid phase bound labeled nucleic acid. The homo-
geneous type of nucleic acid assay uses the interference 
between two labels. In a first method, the two labels are 
linked together and the event of hybridization initiates 
cleavage of the linkage between the two labels. (The labels 
are chosen such that they elicit a signal as soon as they are 
separated.) In a second method, the distance between the 
labels is changed by hybridization events. In this case, the 
labels may be located on one probe or on two separate 
probes having the capability of hybridizing to the analyte 
nucleic acid such that the labels can interact with each other. 
40 extremely shallow, but this interpretation must be regarded 
with caution pending a clear demonstration of redox prod-
ucts. In contrast, there is a report of a covalently linked 
system having Do and Ac metal complexes at the opposite 
ends of an 8 base pair duplex which shows electron transfer 
45 on a microsecond time scale (Meade, T. J.; Kayyem, J. F. 
Angew. Chem Int. Ed. Engl. 1995, 34, 352). In this case the 
redox components were not intercalated within the helix so 
the rate of electron transfer may simply reflect the time 
required to orient the donor and acceptor in order to obtain 
50 sufficient electronic coupling through the i-electron stack 
before long distance electron transfer can occur. Electron transfer between donors and acceptors is to be 
subdivided into two categories. In the first category, the 
donors (Do) and acceptors (Ac) are bound to the DNA 
duplex by non-covalent forces, such as van der Waals', 
electrostatic and hydrogen bonding. In the second class are 
systems where Do and Ac are covalently linked to the DNA 
The earliest demonstration of the first approach was reported 
by Fromherz and Rieger in 1986, who studied photointitated 
electron transfer (PET) from intercalated ethidium to 
surface-associated methyl viologen (romherz, P.; Rieger, B. 
J. Am. Chem. Soc. 1986, 108, 5361). Electron transfer 
products were demonstrated by direct observation of the 
reduced viologen acceptor. However, no special effect of the 
DNA, other than to provide a high effective concentration of 
the donor and acceptor, was observed. In 1992, Harriman 
and Brun reported PET from ethidium and acridine donors 
to diazapyrenium acceptors under conditions where the 
At this time, there are many unresolved questions regard-
ing the ability of duplex DNA to mediate electron transfer. 
None of the systems cited above has unambiguously dem-
55 onstrated the rate or efficiency of electron transfer between 
donor and acceptor moieties held at a fixed distance of 
separation in a DNA/DNA duplex. 
In a modification designed to detect hybridization of 
nucleic acids in homogeneous solution, Tyagi and Kramer 
60 (Tyagi, S.; Kramer, F. R. Nature Biotechnology 1996, 
14,303) describe a doubly substituted single-stranded DNA 
construct that possesses a stem-loop (i.e. hairpin) structure. 
This construct contains a fluorescer covalently linked to one 
terminus of the strand and an energy transfer quencher of the 
65 fluorescer at the opposite terminus. When unconjugated, this 
single stded chain exists predominantly in a hairpin confor-
mation that constrains the fluorescer and quencher to be 
6,117,973 
3 
relatively close in space. When n this structural form, 
excitation of the fluorescer with actinic light leads to 
reduced emission because the fluorescing excited state trans-
fers its energy to the nearby quencher. However, when this 
single-stranded structure hybridizes with a second strand 5 
complementary to its loop region, the distance between the 
fluorescer and quencher is increased and, consequently, the 
efficiency of fluorescence increases. The change in fluores-
cence intensity is an indicator that hybridization has 
occurred. 10 
4 
electron transfer through the duplex under certain condi-
tions. These electron transfer moieties are complexes of 
ruthenium and other heavy metal ions with organic ligands 
which can change electronic state during electron transfer. 
Further in WO 95/15971, there is a suggestion that the 
phosphodiester bonds in an oligonucleotide can be replaced 
by peptide bonds thus using peptide nucleic acids (PNA) as 
bioconductors. 
SUMMARY OF THE INVENTION 
The subject of the present invention is a method for 
determining a nucleic acid in a sample comprising binding 
a probe having a polymeric backbone different from the 
15 natural sugar phosphate backbone of DNA or RNA to the 
nucleic acid by means of base-mediated hydrogen bonding, 
wherein this probe has an electron acceptor or an electron 
donor, or both, bound covalently either at terminal positions 
or at internal positions of the probe molecule. Further, 
The modification described by Tyagi and Kramer offers 
several advantages for homogeneous real-time assays for 
hybridization. However there are certain disadvantages to 
the system they report. First, the indication of hybridization 
relies on energy transfer quenching of the fluorescer. This 
requires that the quencher have a lower excited singlet 
energy than the fluorescer, and his can cause difficulties in 
selecting a quencher whose absorption spectrum does not 
overlap with that of the fluorescer. Second, the nature of the 
hairpin structure requires that a portion of the single-
stranded probe molecule be self-complementary. In general, 
this self-complementary portion will not hybridize with the 
target strand of the nucleic acid to be determined. This 
requirement will reduce the association constant of the 
hybrid duplex DNA A further disadvantage of the modifi-
cation described by Tyagi and Kramer is that covalent 
linkage of the fluorescer and quencher at the terminal 
positions of the single-stranded DNA probe is cumbersome 30 
synthetically and far from ideal for an assay. The long chain 
20 stimulation of the electron donor or electron acceptor by any 
one of several means elicits a different outcome depending 
upon whether the probe molecule is bound to the nucleic 
acid. In particular, the present invention is a method for 
inducing an electron or hole transfer from an electron donor 
25 to that electron acceptor or a hole transfer from said electron 
acceptor to an electron donor and determining the occur-
rence of the electronic transfer as a measure of said nucleic 
acid. It is an object of the present invention to provide a 
method for reliable detection of electron or hole transfer. 
of atoms used to bind the fluorescer and donor to the single 
stranded DNA is flexible and, consequently, the fluorescer 
and quencher will exist in many conformations, even in the 
stem-loop structure, some of which may be ineffective at 35 
quenching the emission of the fluorescer. This will contrib-
ute to a high background fluorescence in assays for hybrid-
ization. Finally, a further disadvantage of covalent linkage of 
the fluorescer and quencher at the terminal positions is that 
unraveling of the stem structure at these positions, which is 40 
commonly to be expected, will increase the distance 
between the fluorescer and quencher, and increase the num-
ber of available conformations. Both of these effects will 
lead to an increase in background emission. 
In a further attempt to modify DNA Shimidzu and 45 
co-workers reported the synthesis and characterization of a 
modified DNA oligomer containing an acridine moiety 
covaently linked at an internal position (Fukui, K.; 
Morimoto, M.; Segawa, H.; Tanaka, K.; Shimidzu, T. Bio-
50 
conjugate Chem. 1996, 7, 349). Hybridization with a 
complementary oligomer containing either a thymine or an 
abasic site at the appropriate position opposite the acridine 
yields a 1:1 duplex with the acridine, apparently, intercalated 
within the helix. Electron transfer to the acridine moiety was 
55 
not reported. 
A further object of the invention is to modify the effi-
ciency or rate of electron (hole) transfer in bioinsulators and 
bioconductors. 
In another aspect, the invention is directed to a method of 
controlling the rate and efficiency of electron (hole) transfer 
with high specificity for the indication of duplex formation. 
From this prior art it is not apparent to one skilled in the 
art that DNA/DNA, DNNPNA and PNNPNA hybrids will 
be bioconductors under all conditions of electron transfer 
driving force and time scale. In particular, electron conduc-
tion (electron transfer or hole transfer) from an electroni-
cally excited state, or other electron donor or electron 
acceptor species not having an essentially infinite lifetime, 
must compete with return of the electronically excited state 
to its ground state, or consumption by some other means of 
the electron donor or acceptor with a limited lifetime. If 
conduction of an electron through a DNA/DNA, DNA/PNA 
and PNNPNAduplex occurs on a time scale longer than the 
return of the excited state to the ground state or consumption 
of the electron donor or acceptor, then the DNNDNA, 
DNA/PNA and PNNPNA duplex will act as if it is a 
"bioinsulator", rather than a bioconductor. 
The molecular and energetic features that control the rate 
and efficiency of electron transfer reactions have been exten-
sively studied. The Marcus theory of electron transfer 
(Marcus, R. A Ann Rev. Phys. Chem. 1964, 15, 155. 
Marcus, R. A J. Chem. Phys. 1965, 43, 679) is remarkably 
successful in its prediction of reaction rates. In its simplest 
Described in WO 95/15971 is the conjugation of oligo-
nucleotides with intercalators that can act as electron donors 
or electron acceptors. The resulting complexes represent a 
series of derivatives that are bimolecular templates whose 
use as probe molecules relies on duplex DNA to provide a 
path for the transfer of electrons over very large distances at 
extremely fast rates. In this role the DNA duplex is described 
as and must function as a "bioconductor". In WO 95/15971 
there is disclosure of a method wherein oligonucleotides are 
labeled at each end with different electron transfer moieties 
and it is demonstrated that these moieties are capable of 
60 formulation ( eqs. 1 and 2), the theory identifies three factors 
that determine the rate constant for electron transfer (ke,). 
These are the driving force (ti.Get) for the reaction, the 
reorganization energy (A.), and the maximum rate constant 
(kmax), which occurs when li.G~=O. In classical theory, 
65 kmax=ke, um where ke, is the electronic transmission coef-
ficient and un is the frequency of passage through the 
transition state. 
6,117,973 
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k" = km~ ·exp(- t.G* / RT) (1) 
(2) 
5 
6 
FIG. 7 shows an embodiment using two complementary 
probes. 
FIG. 8 shows the flow scheme for the preparation of Ql, 
an electron accepting PNA monomer (linker length 1). 
FIG. 9 shows the flow scheme for the preparation of Q2, 
an electron accepting PNA monomer (linker length 4). 
FIG. 10 shows the flow scheme for the preparation of Rl, 
an electron donating PNA monomer (linker length 4). 
Of most relevance to the present invention is the estima-
tion of ke, and its comparison with chemical or physical 
reactions that consume the electronically excited state, or 
other electron donor or electron acceptor species not having 
10 FIG. 11 shows the flow scheme for the preparation of R2, 
an electron donating PNA monomer (linker length 7). 
FIG. 12 shows absorbance/temperature profiles for PNN 
DNA hybrids with different quinone linker lengths for 
different wavelengths. AQ2 stands for PNA579 and AQ5 
15 stands for PNA586. 
an essentially infinite lifetime. If the rate of electron transfer 
from donor to acceptor is greater than the rates of the 
competing chemical or physical reactions, then the electron 
transfer will be more efficient. Formation of a complex 
between the probe and the nucleic acid to be determined can 
change the magnitude of ke, and/or the magnitude of the 
rates of the chemical or physical reactions that consume the 
electronically excited state, or other electron donor or elec-
tron acceptor species not having an essentially infinite 20 
lifetime. Formation of the complex between the probe 
molecule and the nucleic acid to be determined may modify 
ti.Ge, so that the rate of electron transfer increases or 
decreases upon complex formation. Alternatively, complex 
formation can cause changes in the environment of the 
electron donor or electron acceptor such that the rate of 
chemical or physical reactions that consume the electroni-
cally excited state, or other electron donor or electron 
acceptor species not having an essentially infinite lifetime, 
changes relative to the rate for the electron transfer reaction. 30 
Based on Marcus theory, the formation of the complex 
between the probe and the nucleic acid to be determined 
causes a change in the Marcus reorganization energy for the 
electron transfer or a change in the Marcus kmax· A change 
FIG. 13 shows photoinduced cleavage of DNA within 
PNA/DNA hybrids. 
FIG. 14 shows photoinduced cleavage of DNA with an 
8-0xoG site. 
FIG. 15 shows phosphorescence quenching in PNA/DNA 
hybrids due to electron transfer. 
FIG. 16 shows absorbance/temperature profiles for 
PNA626 and 627 hairpins. 
25 FIG. 17 shows absorbance/temperature profiles for 
DNA626A hybrids with PNA626 and PNA627. 
in either parameter may result in either an increase or 35 
decrease in the rate of electron transfer. In the case where 
formation of the complex between the probe and the nucleic 
acid to be determined results in an increase in the ke, the 
resulting complex can be called a bioconductor, since it 
facilitates electron transfer. It is a surprising discovery that, 40 
depending on some specific details of structure, formation of 
the complex between the probe and the nucleic acid to be 
determined results in a decrease in the rate constant for 
electron transfer in the complex. Thus, in some cases, the 
complex formed by the probe molecule and the nucleic acid 45 
to be determined may be a "bioinsulator". 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 shows schematically the long range electron trans-
DETAILED DESCRIPTION 
The term nucleic acid to be determined is understood in 
the present invention as an analyte nucleic acid or a nucleic 
acid derived therefrom. Analyte nucleic acids include 
nucleic acids of any origin, for example, nucleic acids of 
animal, human, viral, bacterial, or cellular origin. They may 
be present in solution, suspension, but also fixed to solid 
bodies or contained in cell-containing media, cell smears, 
fixed cells, tissues, or fixed organisms. Nucleic acids derived 
therefrom are nucleic acids prepared from analyte nucleic 
acids or parts thereof, for example as copies of the above-
mentioned nucleic acids, or parts thereof These copies 
include nucleic acids derived from that original analyte 
nucleic acids by amplification, including any replication 
or/and transcription/reverse transcription reactions, for 
example by the polymerase chain reaction. 
Usually the nucleic acid to be determined will be pre-
treated to get into a condition ready for binding the probe 
molecule, if it is not already accessible. Such pretreatment 
may include denaturing double-stranded nucleic acids by 
changing the pH into the alkaline region, repeating extreme 
temperature changes (freezing/thawing), changing the 
fer (ET) mechanism of the present invention. The concept is 
illustrated by the example where the donor and acceptor are 
located on the same strand. The designations n and m refer 
to the electronic states of the donor and the acceptor. 
FIG. 2 shows a first embodiment of the invention using 
only one probe molecule labelled with a distally positioned 
electron donor (Donor) and an internally positioned acceptor 
(acc.). 
50 physiological probe conditions (osmotic pressure), lysis of 
cell walls by detergents, chaotropic salts or enzymes (e.g. 
proteases, lipase). These steps may be used either alone or 
in combination in order to release the nucleic acids. In some 
instances, it may be advantageous to separate the nucleic 
55 acids from other components of the sample, like proteins, 
cells, cell fragments, but also nucleic acids which are not 
intended to be detected. 
FIG. 3 shows an embodiment of the present invention 
wherein two labelled probes are used. Thus one probe 
contains the acceptor (distally located) and another probe 60 
contains the donor (distally located). 
FIG. 4 shows a format using an immobilised probe 
containing an internally positioned acceptor and donor in the 
same probe. 
FIG. 5 shows the proposed electron transfer mechanism 65 
via hole hopping. 
FIG. 6 shows a format using a hairpin forming probe. 
The probe molecule binding to the nucleic acid is defined 
by having a polymeric backbone different from the natural 
sugar phosphate backbone. Examples of such probe mol-
ecules are now well-known in the art. Those probes may be 
based upon monomeric subunits, which are linked in a 
repetitive way. It is preferable that the probe molecule 
contains at least five monomeric subunits, each monomeric 
subunit being connected to other monomeric subunits by 
peptide bonds. The peptide bond is understood to be the 
bond connecting a primary or secondary amine and a 
7 
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one modified monomeric subunit is contained within the 
probe molecule, these monomeric units should not all be 
located at the final monomeric subunits. 
carboxylic acid residue. Other types of linkages within the 
monomers or connecting one or more monomers in the 
backbone are possible, for example, ether or amino bonds. 
Examples of such probe molecules are described in WO 
92/20702 including probe molecules having ligands bound Preferred probe molecules are compounds of the general 
to aza-nitrogen atoms, WO 94/25477, and WO 96/20212. 
5 
formula I 
Probe molecules having mixed different linkages between 
the monomers are described in EP-A-0 672 677. The term 
probe molecule further contains molecules having the above 
stretch of the non-natural backbone and an additional stretch 
of the natural sugar phosphate backbone. Such chimera may 
10 
possess some lower affinity to complementary nucleic acids, 
but are nevertheless useful in the present invention. 
The term backbone in the present invention shall mean the 
polymeric moiety to which at different points of attachment 
heterocyclic base moieties are bound in a consecutive way. 
15 
The binding of the probe molecule to the nucleic acid is 
accomplished by hydrogen bonds mediated by said base 
moieties on said backbone. Such hydrogen bonding for 
example occurs between complementary nucleobases as in 20 
the base pairing in nucleic acids having the natural sugar 
phosphate backbone or artificial bases eliciting similar prop-
erties for hydrogen bonding to the natural bases. While the 
most prominent mode of binding is by duplex formation, 
some molecules bind to nucleic acids by triplex formation 25 
(see for example WO 95/01370). Artificial bases include 
diaminopurine, pseudouridine, thioguanine and 
7-deazaguanine. The method of the invention requires a 
stretch of at least five consecutive monomeric units coupling 
the bases of the probe molecule. The probe molecule should 30 
have a length of at least 9 base-pairing monomeric units, 
preferably between 9 and 30 and most preferably between 
10 and 25 base-pairing monomeric units. 
Such probe molecules can be prepared by analogy to the 
methods described in the above-mentioned documents. 35 
Their preparation may include techniques usually employed 
in peptide chemistry. However, probe molecules especially 
preferred in the present method include new starting and 
intermediate compounds useful for introducing any electron 
donor or/and any electron acceptor moieties into the probe. 40 
Their preparation will be described later. 
An electron acceptor or an electron donor or an electron 
acceptor and an electron donor are bound covalently to the 
probe molecule at defined, fixed positions, according to the 
invention. The generally possible positions for attaching 45 
moieties to polymeric backbones can be systematically 
divided into a first group wherein the moiety is attached at 
one or both ends of the polymeric backbone, a second group 
wherein at least one of the groups is bound to the polymeric 
backbone at a position on the backbone not located on the 50 
first and the last base bearing monomeric unit of said 
backbone, and a third group wherein the moiety is bound to 
a base position attached at any of the monomeric units. 
Surprisingly, the objects of the present invention are better 
met for the second group. Within this group, such probe 55 
molecules have proven to be the most successful in which 
the nucleobase moiety of one or more of the monomeric 
subunits is replaced totally by a group or groups containing 
the electron acceptor or an electron donor, preferably such 
that the rate or efficiency of electron transfer in the probe is 60 
modified by the nucleobases of the nucleic acid to be 
determined. It is possible not only to modify only one 
subunit by such moieties, but also more subunits, dependent 
upon the overall length of the probe molecule. However, as 
a general rule, it is preferred to not include more than 30% 65 
of modified monomeric units compared to the overall num-
ber of monomeric units in the probe molecule. If more than 
wherein 
n is an integer of from at least 3, 
xis an integer of from 2 to n-1, 
Formula I 
each of L 1-L n is a ligand independently selected from the 
group consisting of hydrogen, hydroxy, (C1-C4)alkanoyl, 
naturally occurring nucleobases, non-naturally occurring 
nucleobases, aromatic moieties, DNA intercalators, 
nucleobase-binding groups, heterocyclic moieties, reporter 
ligands and chelating moieties, wherein at least one of 
L 1-Ln, preferably at least one of L 2-Ln-l is a non-
nucleobase electron acceptor or a donor moiety and at least 
2 of L 1-L n being a nucleobase binding group, or a naturally 
or non-naturally occurring nucleobase; 
each of 11 -Jn is (CR 6 R7 )y (preferably CR 6 R7 , 
CHR 6CHR 7 or CR 6R 7 CH2 ) where R 6 is hydrogen and R 7 is 
selected from the group consisting of the side chains of 
naturally occurring alpha amino acids, or R 6 and R 7 are 
independently selected from the group consisting of 
hydrogen, (CcC6)alkyl, aryl, aralkyl, heteroaryl, hydroxy, 
(CcC6)alkoxy, (C1-C6)alkylthio, NR3R4 and SR5 , where 
R3 and R4 are as defined below, and R5 is hydrogen, 
(CcC 6)alkyl, hydroxy, (CcC 6)alkoxy, or (C1 -C 6 ) 
alkylthio-substituted (CcC6)alkyl or R6 and R7 taken 
together complete an alicyclic or heterocyclic system; or 
C1-cn is CO, CS, CNR3; 
each of D1-Dn is (CR6R7)z (preferably CR6R7 , CHR6 CHR7 
or CH2 CR 6R 7) where R 6 and R 7 are as defined above; 
each of y and z is zero or an integer from 1 to 10, the sum 
y+z being at least 2, preferably greater than 2, but not more 
than 10; 
each of G 1-an- 1 is -NR3CO- -NR3CS-
-NR3SO- or -NR3S02-, in either o;ientation wher~ 
R3 is as defined below; ' 
each of A 1-An and B1-Bn are selected such that: 
(a) A 1-N is a group of formula (I/A), (l!B), (llC) or (l!D), 
and B1-Bn is Nor R3N+; or 
(b) A 1-An is a group of formula (l!D) and B1-Bn is CH; 
Formula !/A 
Formula l/B 
6,117,973 
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-continued 
-tl1 {11f IT C Y C N-C-12 12 R r R s 
-t'J {'}~ r C Y C C-N-12 12 R r R s 
wherein: 
Xis 0, S, Se, NR3 , CH2 or C(CH3 ) 2 ; 
Y is a single bond, 0, S or NR4 ; 
Formula l/C 
Formula l/D 
each of p and q is zero or an integer from 1 to 5, (the sum 
p+q being preferably not more than 5); 
10 
groups, reporter ligands, intercalators, chelators, peptides, 
proteins, carbohydrates, lipids, steroids, nucleosides, 
nucleotides, nucleotide diphosphates, nucleotide 
triphosphates, oligonucleotides, including both oligoribo-
5 nucleotides and oligodeoxyribo-nucleotides, oligonucleo-
sides and soluble and non-soluble polymers and as well as 
nucleic acid binding moieties and 
10 
each of xl and yl is an integer of from 0 to 10. 
Alkoxy- and alkylthio groups contain preferably from 1 to 
4 carbon atoms. 
An example for a fused aromatic moiety is naphthol. A 
heterocyclic moiety is pyridin. Reporter groups are moieties 
that can be detected, like fluorescent compounds, for 
15 example fiuorescein, or moieties that can be recognized by 
another molecular entity, like haptens which can be recog-
nized by an antibody raised against this hapten. 
each of r and s is zero or an integer from 1 to 5, (the sum 20 
r+s being preferably not more than 5); 
In the above structures wherein Q or I is an oligonucle-
otide or oligonucleoside, such structures can be considered 
chimeric structures between PNA compounds and the oli-
gonucleotide or oligonucleoside. 
each R1 and R2 is independently selected from the group 
consisting of hydrogen, (CcC4)alkyl which may be 
hydroxy- or (C 1 -C4 )alkoxy- or (C 1 -C4 )alkylthio-
substituted, hydroxy, (CcC4)alkoxy, (CcC4)alkylthio, 25 
amino and halogen; and 
each R3 and R4 is independently selected from the group 
consisting of hydrogen, (C1-C4)alkyl, hydroxy- or alkoxy-
or alkylthio-substituted (CcC4)alkyl, hydroxy, (C1-C6)-
alkoxy, (C1-C6)-alkylthio and amino; 30 Q and I is independently selected from -C02 H, 
-CONR'R", -S03 H or -502-NR'R" or an activated 
derivative of -C02 H or -S03 H and -NR'R"' 
where R', R" and R"' are independently selected from the 
group consisting of hydrogen, alkyl, amino protecting 
Linkers A 1-An for binding acceptor moieties are gener-
ally preferred at a length of between 1 to 10 atoms, most 
preferred 2 to 6 atoms, for donor moieties at a length of 1 to 
10, most preferred 2 to 8 atoms. 
More preferable are compounds of subgroups Ia-lb based 
on the general formula I wherein 
(Ia): B1-Bn is N and A 1-An is -CO---(CH2) 6-
(Ib): B1-Bn is N and A 1-An is -CO-NR3---(CH2) 2-
(Ic): B1-Bn is CH and A 1-An is -N3-CO---(CH2) 2-
Preferred PNA-containing compounds useful to effect 
binding to RNA, ssDNA and dsDNA and to form triplexing 
structures are compounds of the formula Ila, Ilb and Ile: 
Formula Ila 
L....._ L.,, 
0y(CH2)1 
0 
0 y(CH2)1 
Rh '°'"lr:r-(C~)m (CH,)lr:r-(CH2);n-NH-R NH 
0 R7 R7 p p 
Formula Ilb 
/L /L (\_H2)1 (~2)1 
Rh 
OYNR3 0 OYNR3 
'°'"lr:r-(C~)m ccn0T!J.N-(cH2lm-NH-R NH 
0 R7 R7 p p 
Formula Ile 
0 /L 0 /L )--(CH2)1 )--(CH2)1 R3'- R3'-N N 
Rh 
'°'"lrt-(c'/;l: (O>,),~(Oh)~NU-R NH 
0 R7 R7 p p 
6,117,973 
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wherein: 
each L is independently selected from the definitions of 
L1-Ln in formula I; 
12 
Illa 
each R7 is independently selected from the group con- 5 
sisting of hydrogen and the side chains of naturally occur-
ring alpha amino acids; 
n is an integer greater than 1, 
each k, 1, and m is, independently, zero or an integer from 10 
1 to 5; 
I!Ib 
each p is zero or 1; 
Rh and R; are as defined for R', R" and R"' 
Electron acceptor moieties and electron donor moieties 
are each referred to as electron transfer moieties. They are 
most preferably moieties not including nucleobases (non 
nucleobase moieties). 
Electron acceptors according to the present invention can 
induce oxidation of other moieties by attracting an electron 
from their surroundings particularly after they have been 
stimulated with light or activated by some other means. 
Electron acceptors will typically be electron-deficient spe-
cies. Preferable electron acceptors are organic molecules, 
preferably excluding organic molecules containing metal 
ions. Further, these organic molecules have a generally fiat 
structure with a system of delocalized it-electrons. 
Therefore, organic molecules are especially preferred that 
contain aromatic hydrocarbon moieties containing func-
tional groups, wherein the functional groups may have 
electron-withdrawing properties. It is possible that the elec-
tron acceptor will contain both electron-donating and 
electron-withdrawing functional groups. The substituents 
should not be so bulky that they disturb the regular base 
stacking between the probe and the nucleic acid to be 
determined. The electron deficiency of the electron acceptor 
will normally be increased by excitation with light or with 
stimulation by some other means. In the preferred case there 
15 
wherein X, Y, Z, Q, V and W are independently selected 
20 from the atoms C, N, S, and 0, X, Y, Z, Q, V and Ware 
connected by either single or double bonds. R1-R6 are 
independently selected from the group of R1-R6 are, inde-
pendently from each other, selected from the group of -H, 
-o-, -OH, -OR', -SH, -SR', -NH2, N02, -503 -, 
25 -So2-, -CN, -Po/-, -Po2--, --COOH, -CO-
R', -COOR', -CS-R', CSO-R', -Coo-, -N=N-, 
halogen (-F, -Cl, -Br, -1), -NHR', N(R'R"), or deriva-
tives hereof, or hydrocarbyls or heterocyclyl as defined 
below. R' and R" is chosen from the possible definitions of 
30 R1-R6 . At least one of X, Y, Z, Q, V and W can together with 
the moiety R1-R6 bound thereto also mean -CO-, 
-SO- or -502-. At least one of R1-R6 can also be a 
single or a double bond. 
Hydrocarbyl comprises groups such as alkyl, alkenyl, 
35 alkynyl, each having between 1 and 10 carbon (C)-atoms, 
aryl having 6-30 C-atoms, such as phenyl, naphthyl, 
biphenyl, tolyl, anthracenyl, etc., and combinations of these 
in different substitutions patterns. These hydrocarbyl groups 
may be straight chained or branched chained, symmetric or 
40 asymmetric, chiral or achiral, contain one or more hetero 
atoms selected among -N-, -NH-, -S-, -0-, and 
may also be fused. The hydrocarbyl groups may be unsub-
stituted or substituted by one or more of the above men-
tioned R 1-R 6 . 
is no measurable electron transfer to the acceptor without its 
stimulation in the assay medium. The acceptor moiety will 
typically have well-characterized redox and spectroscopic 
properties, although precise knowledge of these parameters 45 
is not required for their successful application in this inven-
tion. Electron acceptors useful in this invention typically 
undergo a change in chemical or optical properties when it 
accepts an electron. For example, such electron acceptors 
may be useful in this invention when, after conversion by 50 
electron attraction to become a radical anion, or any other 
one electron reduction product, it possesses a unique optical 
spectrum with strong absorption bands. However, the detec-
tion of the change in chemical or optical properties of the 55 
electron acceptor is not required for the successful applica-
tion of this invention. 
Heterocyclyl are preferentially selected among cyclic 
aromatic or non-aromatic moieties containing hetero atoms 
selected among -N-, -NH-, -S- and -0-, pref-
erably selected from the group consisting of pyridyl, 
imidazolyl, pyrimidinyl, pyradazinolyl, quinolyl, 
acridinolyl, pyrrolyl, furyl, thienyl, isoxazolyl, oxazolyl and 
thiazolyl. The heterocyclyl groups may optionally be sub-
stituted by one or more of the above mentioned R1-R6 . 
At least one of said moieties R 1-R 6 is modified such that 
it is capable of binding to the backbone of the probe. 
Preferably the electron acceptor is bound via a free sigma 
bond at one of said moieties to said backbone. It is under-
stood according to the present invention that the acceptor 
moiety is defined as the moiety which is capable and 
responsible for accepting the electron. Any moiety between 
These acceptor moieties are typically composed of one to 
10, preferably 1 to 4, fused cyclic hydrocarbon rings which 
may be substituted or unsubstituted. The cyclic hydrocar-
bons may independently have any ring size ranging from 5-
to 10-membered rings, but preferably include 5- or 
6-membered aromatic rings. The cyclic hydrocarbons may 
be fused in any position isomer. 
Preferably, the acceptor or the donor moiety includes a 
group of general formula Illa or Illb 
60 the backbone and the acceptor is defined to be a linker A 
While this is not the preferred case, the acceptor or/and 
donor moiety can include a complex of a transition metal 
chelated by one or more ligand moieties. Preferred transition 
metals are chosen from the group iron, copper, ruthenium, 
65 rhenium and osmium. 
More preferably, the electron acceptor or donor may 
contain a group chosen from the class of imides. Imides may 
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act as both acceptors and donors. These compounds will 
contain the essential -(C=O)-N(R)-(C=O)- unit 
with the carbonyls placed in a hydrocarbon ring structure 
which is bonded to an aromatic ring system via conjugation 
of the carbonyls. The imide is contained in a hydrocarbon 
ring which may be 5, 6, 7, 9 membered but preferentially a 
5 or 6 membered ring. The acceptor/donor may contain from 
1-10 imides linked via the aromatic system. An acceptor/ 
donor may contain imides of the same ring size or containing 
imides of different ring sizes. The aromatic structure com-
prises of 1-10 fused cyclic aromatic hydrocarbons and 
optionally substituted with the substituents (R). The cyclic 
hydrocarbons may be bonded/fused in any position isomer. 
The cyclic hydrocarbons may independently of each other 
be any ring size (5, 6, 10, 14 membered rings) but prefer-
entially 5, 6 membered aromatic rings which independently 
of each other may comprise one or several hetero atoms 
selected among -N-, -NH, -S- and -0-. Preferred 
imides include groups of general formulae IVa-IVe. 
(R),*"~O \~N-(R 
0 
(R),(~'){('/ ' n 0 
- N-(R) 
(R)1~ j m 0 
0 (R), 0 
R-N~N-R 
0 0 
!Va 
!Vb 
!Ve 
!Vd 
!Ve 
wherein the definitions for R are selected from the possible 
definitions of R 1-R 6 of general formula Illa and Illb and 
wherein n and m is 0 or an integer from 1 to 10 and k, r and 
1 is 0 or an integer from 1 to 4. It is clear that only so many 
substituents R are bound that the valency and charge of the 
atom of attachment of the substituent R is not changed. 
14 
A further preferred moiety is chosen from the group of 
n-alky 1-aza-aromatic compounds. N-alky-aza-aromatics 
may act as both acceptors and donors (formula Va-d, vide 
infra). In these compounds the nitrogen atoms in the aro-
5 matic rings are alkylated. This forms positively charged 
molecules. The aromatic rings where the aza atoms are 
located can be 5, 6, 10, 14 membered rings, but preferen-
tially 5 and 6 membered rings. The acceptor/donor may 
contain 1 to 10 alkylated cyclic nitrogen atoms which are 
10 placed in an aromatic system of 1 to 10 fused aromatic rings. 
The fused cyclic hydrocarbon system may be composed 
of 5, 6, 10, 14 membered aromatic rings, but preferentially 
5 and 6 membered rings, which independently of each other 
may comprise one or several hetero atoms selected among 
15 -N-, -N, -S- and -0-. The acceptor may be 
composed of alkylated cyclic nitrogen atoms of the same 
ring size and/or different ring size. The aromatic hydrocar-
bons carrying the alkylated cyclic nitrogen atoms and/or the 
fused aromatic ring not carrying the alkylated nitrogen 
20 atoms are preferentially substituted (R). 
Within this group compounds of general formulae Va-Vd 
Va 
25 
Vb 
30 
35 Ve 
40 
Vd 
45 
50 
N' 
I 
R 
55 wherein the definitions of the substituents of formula IV 
apply and wherein r is 0 or an integer of from 1 to 4. 
Preferred as acceptors are compounds containing a 
quinoid structure. Such compounds are well-known to one 
skilled in the art. The quinones especially useful in this 
60 invention are composed of at least 2 conjugated carbonyl 
groups (optionally thiono or azo) placed in the same or in 
separate rings fused with 1-10 cyclic aromatic hydrocarbons 
and optionally substituted with the substituents (R 1-R 6) and 
having 2-20 conjugated carbonyl groups in pairs, provided 
65 that the number of conjugated carbonyl groups does not 
exceed twice the number of fused cyclic hydrocarbons. The 
cyclic hydrocarbons may be fused in any position isomer. 
6,117,973 
15 16 
groups are preferably selected from the groups H, -o-, 
-OH, -OR', -SH, -SR', -NH2, -N=N-, -I, 
-NHR', N(R'R"). 
Compounds preferentially acting as donors are corn-
The cyclic hydrocarbons may independently of each other 
be any ring size but preferentially 5, 6 carbon atom mem-
bered aromatic rings which independently of each other may 
comprise one or several hetero atoms selected among 
-N-, -NH, -S- and -0-. The conjugated carbonyl 
groups may be located in any of these rings provided that the 
quinoid structure is maintained. 
Especially preferred quinoid structures contain the gen-
eral formulae Via-Vic. 
s pounds containing an aza-aromatic structure. Examples of 
these compounds are aromatic ring structures containing 
nitrogen The N-heterocyclic structure is bonded/fused with 
a cyclic hydrocarbon system composed of 5, 6, 10, 14 
membered aromatic rings, but preferentially 5 and 6 mem-
0 
(R),~: 
Via 
10 bered rings, which independently of each other may com-
prise one or several hetero atoms selected among -N-, 
-NH, -S- and -0-. The donor may be composed of 
heterocyclic nitrogen containing rings of the same ring size 
and/or different ring size. The aromatic hydrocarbons car-
rying the heterocyclic structure and/or the bonded/fused 
15 aromatic ring system are preferentially substituted. 
0 
Vlb 
0 
(R),~:, 0 
Vlc 
wherein the definitions of the substituents are chosen from 
the definitions of formulae IV and wherein o and p are 0 or 
an integer from 1 to 10 and t and q are 0 or an integer from 
1 to 4. Preferred examples of this group are anthraquinone 
20 
25 
30 
35 
40 
and phenanthraquinone. 45 
As electron donors, generally all compounds are useful 
which can in the ground state or in the electronically excited 
state, or after stimulation by some other means, be oxidized 
by an electron acceptor by giving off an electron. Preferred 
donors are organic molecules, although organic molecules so 
containing metal ions are not excluded. Preferably, the donor 
molecules are chosen such that the electron deficiency 
caused by the oxidation has the consequence of causing a 
change to one or more of its physical or chemical properties, 
whereby detection of the electron deficiency (oxidation ss 
event) is possible. Typical donors will be electron-rich fused 
aromatic systems carrying functional groups and will opti-
mally be substituted. The donor will preferably have an 
aromatic structure substituted by electron-donating groups. 
Therefore, the donors are preferably chosen from the general 60 
formulae III-V, wherein the substitution with electron-
donating groups supersedes. 
Electron-withdrawing groups or electron-attracting 
groups are preferably the groups N02, -503 - , -502 - , 
-CN, -Po/-, -Po2-, -COOH, -CO-R', -COOR', 65 
-CS-R', CSO-R', -Coo-, halogen (-F, -Cl, -Br, 
-I), while electron-releasing groups/electron-donating 
Preferred aza-aromatic structures are compounds of gen-
eral formulae VIia-Viie 
VII a 
Vllb 
Vile 
R R 
-N NH ~ y._,~A-x (R),~ T ~(R)q 
R 
wherein the groups R, n, m, p, o, 1, k, q, and r are chosen 
from the definition of formulae III to VI. 
One possible donor moiety is the natural base guanine and 
derivatives thereof. It has been found in the present inven-
tion that guanine is an effective donor, forming a chemically 
reactive species. 
FIG. 1 shows schematically one embodiment of the 
present invention. The probe strand contains a donor moiety 
D having n electrons and an electron acceptor A having m 
electrons covalently attached. Upon induction of electron 
transfer (ET) one electron is transferred from the donor 
moiety to the acceptor moiety, thereby changing the number 
of electrons in each moiety. 
While applicants do not wish to be bound on this 
hypothesis, it appears that the use of nucleic acid analogues 
allows very selective control of the rate or efficiency of 
electron and hole transfer between a donor and an acceptor 
through modification of the distance or effectiveness of 
electron or hole transport through the -electron stack of the 
DNA or the nucleic acid analogue when bound to a comple-
6,117,973 
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mentary nucleic acid strand. The orientation within such a 
complex is considered to be so rigid that the donor 
(acceptor) after excitation, or stimulation by some means, 
can donate (attract) an electron (hole) from a near-by accep-
tor (donor) or a nucleic acid base. The base where the 5 
electron or hole comes from is now oxidized or reduced and 
probe molecule in the amount exceeding the highest 
expected amount of nucleic acids in the sample. However, in 
order to maintain a low level of background signal, it may 
be advisable to choose the amount of probe molecules to be 
in the order of magnitude of the nucleic acid to be expected. 
As described in WO 95/15971, there are several possibilities 
may bear a positive or negative charge. The acceptor as a 
consequence is negatively charged. When a chemical moiety 
(here a nucleobase) is missing an electron, an "electron 
hole" (or just hole) is created in the molecule. The electron 
hole in the first base can then be filled by transfer of an 
electron from another base (see FIG. 5); this process is 
called hole-hopping. By several such hole-hops, the excita-
tion of the acceptor and subsequent electron transfers yield 
oxidation of a distal position in the binding product (for 
example, a hybrid between the nucleic acid analogue and the 
nucleic acid to be determined). Electron transfer may propa-
gate in the strand where it is initiated but may as well 
propagate in the opposite strand. The rate or efficiency of 
electron or hole hopping will depend on its time scale and 
the time scale of chemical or physical processes that com-
pete for consumption of the excited or stimulated electron 
donor or acceptor. 
to determine the presence of any nucleic acid. The present 
invention, however, requires that at least one probe molecule 
is labelled by an electron donor moiety or an electron 
10 acceptor moiety or both. The ruling principle is that within 
the complex containing the nucleic acid to be determined 
and the probe molecule, there is at least one electron donor 
and at least one electron acceptor moiety. While one of the 
electron donor and electron acceptor moiety must be 
15 covalently bound to the probe molecule, at least one of the 
other species of electron transfer moieties can be located 
either within the same probe molecule, the nucleic acid to be 
determined or another probe molecule. This other probe 
molecule can either have a natural sugar phosphate back-
20 bone or a non-natural nucleic acid analogue backbone, while 
the nucleic acid to be determined preferably has the natural 
sugar phosphate backbone. 
In a first embodiment, a complex is formed by a nucleic 
acid analogue probe molecule having an electron acceptor 
25 moiety bound at an internal backbone position, the nucleic 
acid to be determined or a nucleic acid being the product of 
an amplification process of a nucleic acid to be determined, 
and a further probe nucleic acid analogue probe molecule 
containing an electron donor moiety bound to the backbone 
FIG. 5 shows schematically the process of hole-hopping 
initiated by irradiation at 350 nm for a peptide nucleic acid 
(lower strand) having an electron acceptor exemplified as Q 
within the sequence and replacing a base and a nucleic acid 
(upper strand) having bases B complementary to the bases of 
the peptide nucleic acid. Electron transfer creates a posi-
tively charged base at the nucleic acid (B+) by hole-hopping. 
This positive charge is preferentially transmitted to the 
5'-terminal base of a GG sequence, eventually causing 
chemical damage to this base. Upon treatment with 
piperidine, the linkage between the damaged base and the 
nucleic acid backbone is cleaved. Release of the base then 
permits scission of the analyte backbone, resulting in for-
mation of smaller fragment molecules which can be readily 
detected by electrophoretic or chromatographic techniques. 
One aspect of the present invention is to use this electron 
transfer from an electron donor on the analyte to an electron 40 
acceptor covalently linked to the probe molecule and sub-
sequent cleavage of the analyte to detect hybridization. The 
present invention is further based on the fact that this 
electron transfer is possible only if this complex between the 
nucleic acid to be determined and the nucleic acid analogue 
30 at a non-terminal position, wherein the probe molecules are 
bound to different but adjacently located nucleotide 
sequences on the nucleic acid. It is important to avoid 
interrupting the base-stacking between the binding sites of 
the two probes. As a general rule, the electron donor and the 
35 electron acceptor of two different probe molecules should 
not be at termini facing each other when bound to the nucleic 
acid. It is obvious that groups at the termini facing each other 
would severely hinder the capability of the probes to bind to 
adjacent sequences on the nucleic acid to be determined. 
In a second embodiment, the nucleic acid is labelled to 
contain an electron donor or electron acceptor moiety within 
the it stack. As described for the probe molecule, it is 
therefore preferred to insert a fiat electron transfer moiety in 
place of a nucleobase. Such nucleic acids can for example be 
45 prepared by using a chemically synthesised oligonucleotide 
primer having the electron transfer moiety near the 3'-end. 
During amplification, if the original analyte nucleic acid is 
present, this primer is elongated by attachment of further 
mononucleotides. The probe molecule is then chosen to bind 
is formed, since single-stranded PNA probes react with 
analyte nucleic acids by electron transfer either not at all or 
at a much lower rate if the two strands are not hybridized. 
The rate or efficiency of electron transfer is significantly 
reduced for complexes having an internal mismatch. In this 
aspect of the current invention it is preferable that the 
electron transfer not be reversible. 
50 to a position containing both the part of the primer wherein 
the electron transfer moiety is located and a part of the 
adjacent extension product. 
The sample containing the nucleic acid to be determined For the further determination of the complex, it is impor-
tant that by this binding process a complex is formed having is contacted with the probe molecule in order to create the 
complex between that probe molecule and the nucleic acid 55 at least one electron acceptor moiety and at least one 
electron donor moiety covalently bound to either of the 
probe molecules or the nucleic acid to be determined. Thus, 
the complex contains at least one electron acceptor and at 
least one electron donor. 
to be determined. This complex will form via base-mediated 
hydrogen bonding. Peptide nucleic acids as probe molecules 
have the advantage that they can strand invade into double-
stranded nucleic acids. Therefore, it is not even necessary to 
separate double-stranded nucleic acids into single strands 60 
prior to adding the probe molecule. The binding of the probe 
molecule to the nucleic acid will be made according to 
conditions known to one skilled in the art. Such conditions 
are well described for peptide nucleic acids, for example in 
WO 92/20703, to which is made reference in this respect. 
Because in many cases, the amount of nucleic acids in the 
sample is not evident, it might be preferred to choose the 
The formation of the complex is determined by inducing 
electron transfer from an electron donor within that said 
complex to an electron acceptor within said complex and 
determining the occurrence of this electronic transfer as a 
measure of said nucleic acid. This induction of electronic 
65 transfer of course depends upon the choice of the electron 
donor or/and the electron acceptor. There are at least two 
possibilities to start induction. In the first case, the electron 
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donor is activated to give away an electron to the it-stack 
within the complex. In the second case, the electron acceptor 
is activated to absorb an electron from a moiety within the 
it-stack as described above. Generally, therefore the electron 
acceptor is changed in its electronic configuration, which 
will depend upon the it-systems involved. The activation 
process is described in the following using the example of 
compounds chosen from the general formula V. For 
example, anthraquinone derivatives have an nit* excited 
state electronic configuration. Upon excitation by light, fast 
( ~ 10 ps) intersystem crossing to the triplet state will occur, 
precluding fluorescence emission. However, phosphores-
cence from the triplet state can be observed at low tempera-
tures. This emission is efficiently quenched when the elec-
tron acceptor is intercalated into the it-stack of the complex 
formed due to rapid electron transfer from one of the bases 
adjacent to the intercalation site to the excited electron 
acceptor. When the electron acceptor is not located within 
the it-stack, electronic interaction with the bases is weak at 
best and significantly reduced quenching occurs. 
In a first embodiment therefore the occurrence of elec-
tronic transfer is determined by determining the degree of 
the reduction of quenching compared to the case when no 
nucleic acid to be determined is present. 
The preferred mode of inducing electron transfer in this 
aspect of the invention is therefore the inducement by 
irradiating the sample containing the complex with light at 
a wavelength wherein the activation of the electron acceptor 
is achieved. This will be for the electron acceptors men-
tioned above at wavelength of between 300 nm and 450 nm, 
most preferably between 330 nm and 360 nm. The vessel or 
containment wherein the sample is maintained preferably is 
transparent to the light used, such that the light yield is 
improved. 
20 
electron transfer can be measured by several methods. They 
may include determining the electron transfer itself or may 
comprise the determination of any changes occurring within 
the complex or its components caused by the electron 
5 transfer. It is especially preferred to determine the changes 
within the electron acceptor either immediately after the 
electron transfer or at some time later when the process has 
reached its final state. The most obvious change of the 
electron acceptor is the absorption of the electron, changing 
10 the electronic configuration of the electron acceptor or 
donor. This change can be measured using either chemical or 
spectroscopic properties of the now electron-rich electron 
acceptor. Most preferred are determinations of the spectro-
scopic properties, such as light absorption or emission at 
15 characteristic wavelengths (or quenching thereof). The 
electron-rich electron acceptor may also be determined by 
chemical or physical means such as transferring its excess 
electron to a secondary acceptor or an electrode. 
The electron donor has also changed its chemical and 
20 spectroscopic characteristics by losing an electron. For 
example, if guanine is the electron donor, by losing an 
electron a reactive species is created which renders the 
nucleic acid backbone susceptible to cleavage specifically at 
the site of oxidation by piperidine treatment. This chemical 
25 reaction is known to one skilled in the art. The occurrence 
of electronic transfer can then be determined by detecting 
nucleic acids or probe molecules being shorter in length than 
expected. This can be made either by direct gel-
electrophoresis or after sequencing as well as by liquid 
30 chromatography methods. 
The generation of electron transfer (ET) is preferably 
done in an aqueous environment. Thus, the solvent used is 35 
preferentially water or water containing up to 40% (v/v) of 
In case of electron donors changing their spectroscopic 
characteristics upon losing an electron, the spectroscopic 
characteristics of the modified electron donor can be deter-
mined. Similar to the determination of any changes in the 
acceptor, it is possible to spectroscopically determine the 
presence of the created species using its light absorption or 
an organic medium, preferentially up to 10% (v/v) of an 
organic solvent such as methanol. Higher content of organic 
solvents will not be used due to the instability of duplexes 
formed from nucleic acids and nucleic acid analogues, such 40 
as PNA, under these conditions. 
The solvent will preferentially be buffered and the pH 
range will be 2-12. Buffers can be selected among the 
traditionally used buffers in biological assays, but will often 
be phosphate buffers at pH 7. The salt concentration in the 45 
buffer may vary but will preferentially be in the range of 
between 10 mM and 0.5 M. 
fluorescence at characteristic wavelength. 
A further indication of the electron transfer is quenching 
of a possible luminescence of the electron donor or electron 
acceptor. It is well known to those skilled in the art that 
electronically excited states of many electron donors or 
electron acceptors emit light. Electron transfer reactions can 
effectively quench this emission. In one aspect of this 
invention, quenching of the luminescence of the excited 
electron donor or the excited electron acceptor is the means 
by which formation of the complex between the probe and 
the nucleic acid is determined. For example, luminescence 
from the electron donor or electron acceptor will be reduced 
by formation of the complex if the rate or efficiency of 
It may be advantageous to mix the reaction mixture 
containing the complex during irradiation, such that homo-
geneous inducement is achieved. 
Further possible ways for inducing electron transfer 
include stimulation of the electron acceptor at an electrode 
or by chemical means, or by irradiation with electrons, or by 
subjecting the samples to ionising electromagnetic radiation. 
50 electron transfer is increased by complex formation. In the 
preferred application of this invention, the luminescence 
from the excited donor or acceptor is increased by complex 
formation because the rate or efficiency of electron transfer 
has decreased as a consequence of complex formation. 
The time in which the stimulation conditions are main- 55 
tained depends upon the strength of stimulus. It is apparent 
In addition to the dependence of the reaction rate on the 
free energy, reaction rate will also be dependent on distance. 
to one skilled in the art that if a strong stimulation source is 
used, inducement may be accomplished in a shorter time 
than when using a low strength source. In order to keep the 
time for the assay limited it is preferred to have irradiation 
times of less than 6 hours, more preferably less than 1 hour. 
A practical lower limit for the stimulation time may be less 
than 1 second. At high stimulation power there is a chance 
that damage to either the sample or the sample's environ-
ment will occur. 
The electron transfer induced is determined as a measure 
of the nucleic acid to be determined. The occurrence of the 
In particular, the reaction rate is expected to decrease 
exponentially with distance: 
where r is the distance separating the donor and acceptor and 
60 ~ is a dampening factor with units of distance-1 . The 
dampening factor W a measure of the conductivity of the 
medium: a low ~ will allow electron transfer to occur over 
very long distances while a high ~ will permit electron 
65 
transfer at short distances only. 
There is currently some controversy regarding the ~value 
for duplex DNA: Barton and coworkers have suggested that 
~could be very low ( <0.2 A-1 ) (Murphy, C. J.; Arkin, M. R; 
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Jenkins, Y.; Ghatlia, N. D.; Bossmann, S. H.; Turro, N. J.; 
Barton, J. K.; Science 1995, 262, 1025-1029), while Har-
riman and Brun have measured a 3 value of 0.88 A-1 (run, 
22 
In a preferred mode of the method of the present 
invention, the rate or efficiency of the electron transfer is 
different in the probe and in the probe when bound to the 
nucleic acid. In this case the electron donor and acceptor are A. M.; Harriman, A. J. Am. Chem. Soc. 1992, 114, 
3656-3660). The Barton value would suggest that duplex 
DNA is an exceptional conductor while the Harriman/Brun 
value would suggest that duplex DNA is an ordinary con-
ductor. The Barton value is not well-substantiated by experi-
ment (i.e. the occurrence of electron transfer has not been 
demonstrated) so the Harriman/Brun value seems more 
reliable at this time. It should also be noted that the ~ values 
for PNA-DNAand DNA-DNA could be quite different since 
the electron which is transferred is passing through the 
it-stack and the structures of the it-stacks are quite different 
for the two types of duplexes. 
5 preferably bound covalently to the same probe molecule, 
most preferred at a defined, fixed first distance. Upon 
binding of the probe to the nucleic acid to be determined, the 
distance of the electron donor and the electron acceptor is 
altered, preferably increased, thus decreasing the reaction 
10 rate of the electron transfer. The first distance and the 
distance in the complex (second distance) are not preferably 
designed such that the rate in one of the cases allows the 
occurrence of a detectable process, like fluorescence, which 
the other does not (for example in one case the lifetime of 
the excited state of the fluorescer may be longer than 
required for electron transfer and in the other case the time 
required for electron transfer is longer than the lifetime of 
the excited state). The detectable process will then serve as 
an indication or measure of the electron transfer and thus of 
20 the presence or absence of a nucleic acid to be detected. 
If one assumes a "normal" ~value of ca. 1.0 A-1, then a 15 
change in distance from 10 to 20 A would decrease the 
electron transfer rate by more than four orders of magnitude. 
Such a strong dependence of the electron transfer rate on 
distance is the foundation of our distinction between bio-
conductors and bioinsulators, particularly with respect to the 
severe time constraints imposed on the system by using 
photoinduction. The excited state species used as either the 
donor or acceptor will exist for a relatively short time. In a 
preferred embodiment, the donor absorbs photon and has a 
relatively short lifetime, meaning it will relax to the ground 25 
state within a few nanoseconds of excitation. This relaxation 
can occur by several mechanisms but the most important 
pathway is fiuorescense, in which photon of light is emitted. 
In the presence of a suitable electron acceptor, resulting in 
A preferred method of the invention therefore is a method 
wherein the distance between acceptor and donor is a probe 
is altered upon binding to the nucleic acid, preferably by 
more than 5 base units in a stack. 
In order to evaluate the results from determining of the 
occurrence of the electronic transfer, one skilled in the art 
will correlate the signals or results received from experi-
ments wherein the amount or presence of a nucleic acid to 
be determined is defined. This can then be made by usual 
a decrease in the fluorescence. "Suitability" is determined by 
the acceptor reduction potential: ideally, the potential will be 
sufficiently low to yield a negative free energy for electron 
transfer. If the potential is too high, then the electron transfer 
will be too slow to compete effectively with fluorescence 
and little quenching will result. Therefore, the strong depen-
dence of electron transfer rates on distance indicate that, 
with the proper donor/acceptor pair, one can convert a 
system from a bioconductor to a bioinsulator simply by 
increasing the donor-acceptor separation distance. The key 
30 calibration experiments, for example, using standard 
samples containing different specified amounts of nucleic 
acids to be determined in subjecting the standards to the 
same conditions as the sample suspected to contain the 
nucleic acid to be determined. Qualitative and quantitative 
35 determination is possible. 
An important feature of the formation of the probe-
analyte complex is that the distance between the donor and 
acceptor is relatively fixed. 
While these are the core steps of the method of the present is to increase the distance (decrease the reaction rate) until 
the electron transfer becomes too slow to compete with 
fluorescence. 
40 invention, this method can be adapted to known convenient 
formats, for example, by introducing this concept into assays 
wherein the nucleic acid to be determined is determined in 
an immobilized state. A very advantageous format of the 
In the PNA hairpin system we take advantage of the large 
increase in distance separating the donor and acceptor after 
hybridization in order to inhibit electron transfer. The fact 
that we observed significantly more fluorescence after 45 
hybridization than in the hairpin conformation indicates that 
~ is not very small. However, the lack of complete quench-
ing in the hairpin (i.e. a non-black background) arises 
because the free energy for electron transfer is not optimum 
for the acridine/quinone pair, so even in the folded 50 
conformation, the fluorescence and electron transfer are 
competing. Two things can be done to improve the system: 
(i) A more easily-oxidize(reduced) donor(acceptor) will 
increase the electron transfer rate; (ii) A longer-lived excited 
state will decrease the fluorescence rate. The ideal fluorescer 55 
will have a short lifetime (the shorter the better), a high 
quantum yield, a low intersystem crossing rate, energetics so 
that energy transfer to the anthraquinone is impossible but 
that electron transfer is fast, be fiat so that it intercalates in 
the hairpin and the duplex without messing up base-pair 60 
recognition by hydrogen bonding, absorb where the 
anthraquinone does not, fluoresce in the "red" region of the 
spectrum, and it should also be easy to synthesize. 
Such ideal fiuorescor would give a substantially black 
background when no nucleic acid to be determined is 65 
present and bright fluorescence in the complex of probe and 
nucleic acid. 
present invention is disclosed in FIG. 2. In this homoge-
neous (i.e. single solution) format, the sample containing the 
nucleic acid to be determined (comp. target DNA) and 
nucleic acids not to be determined (non-comp. target) in 
soluble form, the probe molecule containing the electron 
acceptor and an electron donor are mixed. Only nucleic 
acids to be determined will hybridize to the specific probe 
molecule. Nucleic acids not complementary to the probe 
molecule will not hybridize. Therefore, after inducement of 
electron transfer, there will be higher or lower light emission 
from the donor or acceptor if the nucleic acid to be deter-
mined was present. 
In FIG. 3, the same homogeneous format is described 
wherein one probe containing an acceptor and another probe 
containing a donor is used. Only binding of both probes 
adjacent to each other, whereby the electron transfer is 
capable of propagating from donor to acceptor will yield a 
change in light emission. 
In FIG. 4, a heterogeneous assay format is disclosed. The 
probe molecule containing both an electron acceptor (acc.) 
and an electron donor (Donor) is bound to a solid phase, for 
example, a polystyrene surface. This can be accomplished 
either by covalent bonding or using streptavidin-coated 
surfaces and biotin-labeled probes. Upon excitation of the 
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ing a nucleic acid in a sample as the nucleic acid analogue 
probe molecule. These compounds can be prepared analo-
gous to the synthesis described in WO 92/20702, WO 
94/25477, WO 96/20212, EP-0 672 677 and EP-0 700 928, 
electron acceptor, electron transfer is induced on the solid 
phase, and can be detected by identifying the modified donor 
only if the nucleic acid to be determined was bound to the 
solid phase near base-pairing via the immobilized probe 
molecule. The assay format using an immobilized probe is 
especially advantageous if the sample contains further ingre-
dients disturbing the irradiation of a detection, for example, 
by absorbing light in the range of the irradiation or emission 
wavelength. 
In an embodiment the nucleic acid to be determined is 
bound by nucleic acid analyte probe molecules capable of 
forming a hairpin structure. In this design, the electron donor 
(Do) and acceptor (Ac) are initially brought into relatively 
close proximity by the nature of the hairpin structure (FIG. 
5 just replacing one or more monomers used in the oligom-
erisation with one ore more monomers containing non-
nucleobase containing electron acceptors or non-nucleobase 
containing electron donors. A preferred way to produce the 
compounds of general formula I is the step-wise chemical 
10 synthesis according to WO 92/20702, incorporating as a 
monomer a compound of the general formula VIIIa-VIIIc 
6). The close location of the electron transfer moieties will 
generally lead to high electron transfer rates and efficiencies 15 
between these two groups. Thus, spectroscopic changes 
induced by electron transfer will be pronounced. This could, 
for instance, be either luminescence initiation or lumines-
cence quenching by electron transfer. A preferred applica-
tion of this invention is the case when duplex DNA or the 20 
DNA-PNA complex of the probe and the nucleic acid to be 
determined has the characteristic of a bioinsulator. In this 
case when the hairpin probe is hybridised to a target nucleic 
acid (e.g. a PCR amplicon) electron transfer rates will be 
reduced compared with the rate in the probe itself and, 25 
therefore, less or no luminescence quenching will be 
observed from the complex than from the probe. 
A hairpin structure is synthesized preferentially in a 
parallel mode. It consists of two hybridisable segments and 
a hinge segment (a segment linking the hybridisable 30 
segments). The two hybridisable segments are complemen-
tary to each other and to two non-overlapping segments of 
the nucleic acid to be determined. Due to the parallel 
synthesis of the whole hairpin, the two segments will form 
an antiparallel duplex. The two hybridisable segments are 35 
preferentially composed of 6-12 monomers each, each seg-
ment containing an electron transfer moiety capable or not 
capable of forming hydrogen bonds. The electron transfer 
moieties are preferentially placed in such a way that they are 
juxtaposed in the hairpin structure on that one of them is an 40 
electron donor and one of them is an electron acceptor. The 
close positioning of the electron transfer moieties makes 
electron transfer as optimal as possible. The preferred dis-
tance of the electron transfer moieties on different segments 
is between 1 and 10, more preferably 1 and 5 when the 45 
segments are hybridized to each other (a distance of 0 
meaning base positions forming hydrogen bonds with each 
other, if bases were present at this position). The hinge 
segment is composed of 2-7 monomers, preferentially com-
posed of 3-5 monomers. 50 
In another embodiment the close electronic interaction 
between the donor and the acceptor is also used (see FIG. 7). 
In this embodiment the analyte specific probe (PNA2) 
contains the donor (or the acceptor). A second probe (PNAl) 
containing the other electron transfer moiety is complemen- 55 
tary to a part of the first probe. When these are hybridised the 
interaction between the acceptor and the donor is as outlined 
above. When the analyte is introduced to the mixture, the 
short acceptor probe will be displaced by the analyte thus 
preventing the electron transfer interaction between the 60 
donor and the acceptor. Depending on the choice of donor/ 
acceptor this could lead to either luminescence initiation or 
quenching. 
VIII a 
or 
VIIIb 
or 
VIIIc 
wherein the definitions of A, B, J and D are chosen from the 
definitions ofA1-An, B1-Bn, 11-r and D1-Dn in formula I, 
respectively with the condition that any amino groups 
therein may be protected by amino protecting groups; E is 
COOH, CSOH, SOOH, S02 0H or an activated derivative 
thereof; Fis NHR3 or NPgaR3 , where R3 is as defined above 
and Pga is an amino protecting group and L is a non-
nucleobase electron donor or acceptor moiety. 
Preferred monomers are amino acids having formula (IX) 
o~ 
X'OOCYN~ 
NHPga 
R7 
IX 
wherein X' is a carboxylic acid protection group or 
hydrogen, R 7 is independently selected from the group 
consisting of hydrogen and the side chains of naturally 
occurring alpha amino acids, or amino-protected and/or acid 
terminal activated derivatives thereof. 
Therefore, a preferred method of preparing a molecule of 
general formula I is characterized in that a molecule of 
general formula VIIIa-VIIIc or IX wherein X' is hydrogen 
is reacted with a compound of general formula X 
(X) 
wherein Further subject matter of the invention are molecules of 
the general formulae I and II. 
The compounds of the general formula I can be used 
advantageously in the above-disclosed method for determin-
65 K is a solid phase, like amino modified glass, or a solid phase 
bound or free compound of general formula I or II or a 
compound of formula I in protected form. These compounds 
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can further be modified by attaching monomeric units not 
containing an electron transfer moiety. 
Any reactive groups like primary amino groups or 
hydroxyl groups are preferably protected by removable or 
non-removable protecting groups, like benzyloxycarbonyl, 5 
Boe or Fmoc if they are not intended to react in the 
elongation reaction. 
The following examples shall explain the invention in 
more detail using PNA as an example of a probe molecule. 
The PNA oligomers described above are synthesised by 
10 
solid phase synthesis procedures. The preferred solid sup-
port is polystyrene but also other solid supports such as 
®Tentagel and ®Controlled Pore Glass may be used. The 
synthesis proceeds from the C-terminal position of the PNA 
and proceeds via couplings of monomers and/or amino acids 
protected with acid labile protecting groups. Reactive 15 
groups on the bases/side chains are also protected. After 
deprotection of the moiety directly linked to the solid 
support the subsequent building blocks (monomers/amino 
acids) are then coupled in the desired sequence. The depro-
tection of the N-terminal position is performed prior to 20 
coupling of the following monomeric unit. 
The coupling of the monomeric unit is performed via 
activation of the carboxylic residue. Such activation is well 
known to those skilled in this art and, as examples, are: 
HATU, HETU, and carbodiimides. The coupling is per- 25 
formed in solvents normally used in peptide chemistry, that 
is NMP, DMF, acetonitrile, pyridine, dichloromethane or 
mixtures thereof Activation enhancers such as DMAP may 
be added. The activated monomeric derivative will be used 
in excess to the previously deprotected residue and typically 
30 in a 2 to 10 times excess. If a high coupling yield is detected 
(typically >99%) the coupling step will be followed by a 
capping step, which comprises treatment of the coupled 
resin bound oligomer with acetic anhydride. The capping 
mixture comprises 2-20% (v/v) acetic anhydride in NMP/ 
pyridine. If unsatisfactory coupling is detected the coupling 35 
step will be repeated to obtain a high coupling yield. 
Coupling of a conjugate containing a carboxylic acid can 
be done analogously to the above described procedure. 
Other ligands not containing a carboxylic acid can also be 
linked to the resin bound oligomers. Such other linkages can 40 
be performed via isocyanates, isothiocyanates (e.g. fiuores-
cein isothiocyanate ), carbonic acid active esters, and sul-
phonyl chlorides. 
The described stepwise synthesis of PNA can be per-
formed manually or automatically. In the latter case com- 45 
mercially available synthesisers (e.g. peptide synthesisers, 
multiple peptide synthesisers, DNA synthesisers) can be 
used, provided that the hardware in the instruments is 
compatible with the chemistry used during the PNA syn the-
=· ~ 
The synthesised oligomer is finally removed from the 
resin. This is preferentially done by treatment with strong 
acid, such as TFMSA or HF. The purification of the liberated 
oligomer is done by HPLC and/or ion exchange. The iden-
tity of the pure material is confirmed by mass spectrometry 55 
and HPLC. 
The letter designation of amino acids and the orientation 
of PNA follows the traditionally used nomenclature. 
EXAMPLES 
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Boe tert-Butyloxycarbonyl 
Rl Designates a monomeric unit composed by: 3,7-diaza-
(N3 -boc-aminoethy l)-(N7 -9-acridinyl)-4-oxo-heptanoic 
acid 
R2 Designates a monomeric unit composed by: 3,10-diaza-
(N3 -boc-aminoethy l)-(N10-9-acridiny1)-4-oxo-decanoic 
acid 
DCC Dicyclohexylcarbodiimide 
DCM Dichloromethane 
DIEA Diisopropylethylamine 
DMAP Dimethylaminopyridine 
DMF Dimethylformamide 
ET Electron Transfer 
HATU 0-(7-Azabenzotriazole-l -yl)-1, 1,3 ,3-
tetramethyluronium -hexafiuorophosphate 
HETU 0-(7-Benzotriazole-l-yl)-1,1,3,3-
tetramethyluronium -hexafiuorophosphate 
HOBT 1-Hydroxybenzotriazole 
NMP N-methylpyrrolidinone 
NMR Nuclear magnetic resonance 
PNA Peptide nucleic acid according to WO 92/20702 
TFA Trifiuoroacetic acid 
TFMSA Trifiuoromethanesulphonic acid 
HF Hydrogen fluoride 
AQ Anthraquinonoes (genus) 
Oligomers are designated according to the PNA numbers 
assigned by PNA Diagnostics. 
Example 1 
Synthesis of 3,6-Diaza-(N3-2-anthraquinoyl)-N6 -
Boc-hexanoic acid (Q1 , FIG. 8) 
Anthraquinone-2-carboxylic acid (2 g, 7.9 mmol), DCC 
(1.7 g, 8.3 mmol), HOBT (1.08 g, 8.0 tmmol) and methyl 
(N-(2-Boc-aminoethyl))glycinate (2 g, 8.6 mmol) were dis-
solved in DMF (25 mL) and stirred at room temperature 
overnight. The reaction mixture was filtered and the filtrate 
was washed with DCM (2x25 mL). The solution was 
extracted with diluted NaHC03 (3x25 mL), 2 M NaHS04 
(2x25 mL) and brine. The organic phase was dried with 
MgS04 , filtered and evaporated to dryness under reduced 
pressure. The yellow foam was dissolved in THF (10 tmL) 
and 1 M LiOH (30 mL) was added. The mixture was stirred 
for 2 h. THF was removed from the solution under reduced 
pressure and pH was adjusted to 2.8 with 2 M NaHS04 . The 
precipitate was extracted with DCM (2x25 mL), evaporated 
to dryness and then redissolved in ethyl acetate (3 mL). The 
ethyl acetate solution was poured into hexane (150 mL) 
whereby the target molecule precipitated. Yield 3.1 g (87%). 
H1 -NMR DMSO-d6 I\: 7.81-8.30 (m, 7 H, aromatics); 
6.98 and 7.72 (m, 1 H, BocNH); 4.17 and 3.97 (s, 2 H, 
CH2 0); 3.52 and 3.24 (m, 2 H. CH2); 3.21 and 3.02 (m, 2 
H, CH2); 1.17 and 1.19 (s, 9H,Boc). 
Example 2 
Synthesis of 3,6-Diaza(N3 -Boc-aminoethyl)-4, 7-
dioxo-7-(2-anthraquinyl)-heptanoic acid (Q2 , FIG. 
9) 
Abbreviations 
Ql Designates a monomeric unit composed by: 3,6-Diaza-
(N3 -2-anthraquinoyl)-N6 -boc-hexanoic acid 
Q2 Designates a monomeric unit composed by: 3,6-Diaza 
(N3-boc-aminoethy 1)-4, 7-dioxo-7-(2-anthraquiny 1)-
heptanoic acid 
60 Methyl 4-(2-anthraquinyl)-4-oxo-3-aza-butanoate 
Anthraquinone-2-carboxylic acid (3 g, 11.9 mmol), DIEA 
(3.1 ml, 24 mmol) and HATU (4.5 g, 11.9 mmol) in DCM 
(30 mL) was stirred for 10 min at room temperature. Methyl 
65 glycinate hydrochloride (1.5 g, 11.9 mmol) was added after 
which the product started to precipitate. The mixture was 
stirred for an additional 3 h. The precipitated material was 
6,117,973 
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collected by filtration. The volume of the mother liquor was 
reduced to 1/3 and an additional crop was collected. Yield 
3.65 g (93%) 
4-(2-Anthraquinyl)-4-oxo-3-aza-butanoic acid 
Methyl (2-anthraquinoyl)-3-aza-butanoate (3.65 g, 11.3 
mmol) was stirred for 1 h at room temperature in lM LiOH 
(20 mL) and THF (3 mL) whereby the starting material 
dissolved. pH of the solution was adjusted to 2.8 with 2 M 
NaHS04 and the target molecule precipitated. The organic 
solvents were removed from the suspension under reduced 
pressure and the precipitate was collected by filtration and 
dried. Yield 3.5 g (100%). 
H1 -NMR DMSO-d6 I\: 9.37 (t, 1 H, NH); 8.67 (d, 1 H, 
H-laq); 8.36 (dd, 1 H, H-3aq); 8.30 and 8.28 (1 H, H-4aq); 
8.23 (m, 2 H, H-5 and H-8aq); 7.95 (m, 2 H, H-6 and H-7aq); 
4,00 (d, 2 H. CH2). 
3,6-Diaza(N3 - Boc-aminoethyl)-4,7-dioxo-7-(2-
anthraquinyl)-heptanoic acid (Q2) 
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3, 7-diaza-(N3 - Boc-aminoethy l)-(N7 -9-acridiny1)-4-
oxo-heptanoic acid (R1) 
A mixture of 9-(2-caboxyethyl)aminoacredine (1.7 g 6.4 
5 mmol), DEA(l.8 g 13.8 mmol) and HATU 2.68 g, 7 mmol) 
was stirred in DMF (40 ml) at room temperature for 10 min. 
Methyl-Boc-aminoethylglycinate (1.8 g, 7.8 mmol) was 
added and the solution was stirred at 60° C. for 4 h. The 
solution was cooled and DCM (100 ml) was added. Subse-
10 quently the solution was extracted with 0.5 M NaHC03 
(3x40 ml), 2 M NaHS04 (2x40 ml) and brine. The organic 
fase was dried with MgS04 and evaporated yo dryness. The 
residue was dissolved in THF/1 M LiOH (2/10) 60 ml The 
pH of the solution was ajusted to 2.8 with NaHS04 wheby 
15 an oil precipitated. The waterfase was decanted off and the 
oil was dissolved in ethanol (10 ml). The solution was purred 
into ether and 3, 7-diaza-(N3 -Boc-aminoethyl)-(N7 -9-
acridinyl)-4-oxo-heptanoic acid (R1 ) precipitated. Yield 2.3 
g (77%) 
20 Hl-NMR DMSO-d6 I\: C16H30N4 0 5: 8.50 (dd, 2 H. acr. 
4-(2-Anthraquinoyl)-4-oxo-3-aza-butanoic acid (3.5 g 
11.5 mmol), DCC (2.6 g, 12.65 mmol), HOBT (1.7 g, 12.65 
mmol) and methyl (N-(2-Boc-aminoethyl)) glycinate (3.2 g, 
13.8 mmol) was stirred in DMF (50 mL) at room tempera- 25 
ture for 48 h. The reaction mixture was filtered and the 
residue was washed with DCM (2x30 mL). The organic 
phase was extracted with diluted NaHC03 (3x30 mL), 2 M 
NaHS04 (2x30 mL), brine, dried with MgS04 and evapo-
rated to dryness. Crystallization from ethyl acetate gave 4.0 30 
g (67%) of methyl 3,6-Diaza(N3 -Boc-aminoethyl)-4,7-
dioxo-7-(2-anthraquinyl)-heptanoate. The methyl 3-aza-3-
(N -2-B oc-amonoe thyl)-4, 7-dioxo-6-aza- 7-(2-
anthraquinoyl)-heptanoate was hydrolysed at room 
temperature in 1 M LiOH and 10% THF. The pH of the 35 
solution was adjusted to 2.8 with 2 M NaHS04 and the target 
molecule precipitated as an oil. The oil was extracted with 
ethyl acetate and the organic phase was dried with MgS04 . 
The volume was reduced to 2 mL and hexane (250 mL) was 
added with stirring, whereby 3-aza-3-(N-2-Boc- 40 
amonoethy 1)-4, 7 -dioxo-6-aza-7 -(2-an thr aquinoy 1)-
heptanoic acid precipitated. Yield 3.7 g (92%). 
1, 8); 7.91 (m, 2 H, acr. 2, 7); 7.84 (m, 3 H, acr. 3,6 and 9 
NH); 7.49 (m, 2 H, acr. 3,6); 6.89 and 6.76 (m, 1 H, BocNI); 
4.28 (m, 2 H, CH2 CO); 4.05 and 3.92 (s, 2 H, CH2 CO); 2.82 
(m, 2 H, CH2 N). C25H30N4 0 5 : calc/found: 466/466 
Example 4 
Synthesis of 3,10-diaza-(N3 -Boc-aminoethyl)-(N10-
9-acridinyl)-4-oxo-decanoic acid (R2 , FIG. 11) 
9-(5-Carboxypentyl)-aminoacridine 
6-Aminohexanoic acid (1.47 g, 11.2 mmol) was added to 
a solution of 9-phenoxyacridine (2.7 g, 10 mmol) in phenol 
(15 g). The suspension was stirred at 120° C. for 2 h. The 
solution was cooled to room temperature and poured into 
ether whereby the product precipitated as a yellow-green 
solid. It was triturated with hot ethanol, filtered then washed 
with ethanol, giving crude 9-(5-carboxypentyl) ami-
noacridine.Yield 2.4 g (78%). 
H1 -NMR DMSO-d6 I\: 8.27 (d, 2 H, acr. 1, 8); 7.61 (m, 4 
H, acr. 2,3,6,7); 7.26 (m, 2 H, acr. 4, 5); 3.79 (t, 2 H. 
CH2 CO); 2.16 (t, 2 H, CH2 N); 1.72, 1.50 and 1.37 (m, 2 H, 
CH2). C19H20N2 0 2 : calc/found: 308/308 H
1
-NMR DMSO-d6 I\: 12.64 (s, 1 H, COOH); 9.14 (m, 1 
H. NH); 8.69 (d, 1 H, H-laq); 8.67 and 8.35 (dd, 1 H, H-3aq); 
8.32 and 8.30 (dd, 1 H, H-4aq); 8.25 (m, 2 H, H-5 and 45 
H-8aq); 7.96 (m, 2tH, H-6 and H-7aq); 6.90 and 6.75 (t, 1 
3,10-diaza-(N3 - Boc-aminoethyl)-(N10 -9-acridinyl)-
4-oxo-decanoic acid (R2 ) 
H, BocNH); 4.24 (d, 2 H, CH2 CO); 4.24 and 4.12 (dd, 2 H, 
CH2 CO); 3.90 (s, 2 H, CH2 CO); 3.44, 3.17 and 3.06 (m, 2 
H, CH2); 1.40 and 1.38 (s, 9 H, Boe). 
Example 3 
Synthesis of R1 (FIG. 10) 
9-(2-Carboxyethyl)aminoacridine 
~-Alanine (1 g, 11.2 mmol) was added to a solution of 
9-phenoxyacridine (2.7 g, 10 mmol) in phenol (15 g). The 
suspension was stirred at 120° C. for 2 h. The solution was 
cooled to room temperature and poured into ether whereby 
the product precipitated as a yellow-green solid. It was 
triturated with hot ethanol, filtered and then washed with 
ethanol, giving crude 9-(2-carboxyethyl)aminoacridine. 
Yield 1.9 g (71 %). 
H1 -NMR DMSO-d6 I\: 8.27 (d, 2 H, acr. 1,8); 7.59 (m, 4 
H, acr. 2,3,6,7); 7.26 (m, 2 H, acr. 4, 5); 4.05 (t, 2 H, 
CH2 CO); 2.82 (m, 2 H, CH2 N). C16H14N2 0 2 : calc/found: 
266/266. 
A mixture of 9-(5-carboxypentyl)aminoacridine (1 g, 3.2 
mmol), DIEA (0.9 g, 6.9 mmol) and HATU (1.34 g, 3.5 
50 mmol) was stirred at room temperature for 10 min in DMF 
(30 mL). Methyl-Boc-aminoethylglycinate (0.9 g, 3.8 
mmol) was added and the solution was stirred at 60° C. for 
4th. The solution was cooled and DCM (60 mL) was added. 
Subsequently the solution was extracted with 0.5 M 
55 NaHC03 (3x30 mL), 2 M NaHS04 (2x30 mL) and brine. 
The organic phase was dried with MgS04 and evaporated to 
dryness. The residue was dissolved in TBF/lM LiOH (2/10) 
(40 mL). The pH of the solution was adjusted to 2.8 with 
NaHS04 whereby an oil precipitated. The water phase was 
60 decanted off and the oil was dissolved in ethanol (5 mL). The 
solution was then poured into ether and 3N-(Boc-
amino e thy 1)-1 ON -( 9-acridiny 1)-3, 1 O-diaza-4-oxy-
nonanicacid precipitated. Yield 1.2 g (76%). 
H1 -NMR DMSO-d6 I\: 8.51 (d, 2 H, acr. 1, 8); 7.90 (m, 2 
65 H, acr. 2, 7); 7.82 (m, 2 H, acr.3, 6); 7.71(m,1 H, NH); 6.83 
and 6.45 (m, 1 H, BocNH); 7.51 (m,2 H, acr. 4, 5); 4.01 (m, 
2 H, CH2 CO); 3.98 and 3.88 (s, 2 H, CH2 CO); 3.23, 3.00, 
6,117,973 
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2.30, 2.03 and 1.88 (m, 2 H,CH2); 2.16 (t, 2tH, CH2 N); 
C27H36N4 0 5 : calc/found: 508/508. 
Example 5 
Synthesis of 3,6-Diaza-(N3 -acetyl, N6-Boc)-
hexanoic acid 
To a solution of methyl N-(3oc-aminoethyl)glycinate (2 g, 
8.6 mmol) in DCM (30 mL) was added acetic anhydride (0.9 
g, 8.8 mmol) and pyridine (1 mL). The mixture was stirred 
at room temperature for 2 h. The reaction was extracted with 
0.5 M NaHC03 (3x30 mL), 2 M NaHS04 (2x30 mL) and 
brine. The organic phase was dried with MgS04 and evapo-
rated to dryness. The residue was dissolved in THF/LiOH 
(lM) 2/10 ( 40mL) and stirred for 1 h after which the pH was 
adjusted to 2.8 with NaHS04 . The solution was extracted 
with ethyl acetate and the organic phase was dried with 
MgS04 ; 3,6-diaza-(N3 -acetyl, N6 -Boc)-hexanoic acid was 
collected by evaporation to dryness. Yield 1.8 g (82%). 
30 
Samples were prepared consisting of equimolar concen-
trations of PNA and DNA oligomers (1.0 or 2.0 µMeach) in 
1.0 mL of 10 mM sodium phosphate buffer (pH=7.0). The 
PNA strand will often precipitate upon addition of the 
5 phosphate, presumably due to complexion of the lysine units 
by the phosphate. Mixing and addition of the DNA strand 
results in dissolution of the PNA. Samples were placed in 
cuvettes (1.5 mL capacity, 1.0 cm pathlength) and sealed 
with tape to prevent evaporation of water during heating/ 
10 cooling cycles. The absorbance of the samples at 260 nm 
was monitored as a function of temperature for three con-
secutive runs: heating at 1.0° C./min, and cooling at 0.5° 
C./min and heating again at 0.5° C./min. In two experiments 
the absorbance was monitored at 330 nm, where the AQ unit 
15 absorbs. Due to the low extinction coefficient of the AQ, 
these experiments were performed at 20 µM each of PNA 
and DNA 
H1 -NMR DMSO-d6 I\: 12.31 (s, 1 H, COOH); 6.83 and 
6.69 (t, 1 H, BocNH); 4.07 and 3.89 (s, 2tH, CH2 CO); 3.30 
(m, 2 H, CH2); 3.09 (m, 2 H, CH2 ); 2.00 and 1.89 (s, 3 H, 20 
CH3 ); 1.37 (s, 9 H, Boe). 
Data were analysed by exporting as an ASCII file and 
importing into a standard graphics software. The absorbance 
was plotted versus temperature for each sample. Melting 
temperatures (Tm) were determined as the maxima of plots 
of the first derivative of absorbance with respect to 
temperature, assuming a first order phase transition. Tm 
values given in the text and tables have error values of ±0.5° 
Example 6 
Synthesis of PNA Oligomers 
25 c. The monomers described above were essentially incor-
porated by the oligomerisation procedure previously 
described and what has been disclosed in WO 92/20702. 
However, the PNA syntheses containing the donor moieties 
constituted a special case because the capping step was 
omitted in the part of the synthesis including and following 30 
the donor monomer. However, to obtain high coupling yields 
the monomeric moieties of this part of the synthesis was 
double coupled. Later experiments have shown that capping 
may be used during oligomerisation of donor containing 
molecules. All oligomers were cleaved from the resin by 35 
TFMSA and subsequently HPLC purified. The identity was 
confirmed by mass spectroscopy (MALDI-TOF). 
PNA 554: calc./found: 5237/5239 
PNA 555: calc./found: 5469/5467 
PNA 579: calc./found: 5429/5426 
PNA 586: calc./found: 5336/5333 
PNA 626: calc./found: 6631/6636 
PNA 627: calc./found: 6563/6564 
Example 7 
Estimation of PNA Concentrations 
Concentrations of PNA stock solutions were estimated by 
UV absorbance at 260 mn. The extinction coefficients of the 
40 
45 
An initial question to address regarded what could be 
tolerated on the DNA strand at the central site, i.e. directly 
across from the AQ in the hybrid. Five variations were 
considered: (1) An abasic site (X) was incorporated into the 
oligomer. This residue replaces the standard DNA base with 
a hydrogen atom at carbon-1 of the deoxyribose moiety and 
would be expected to provide the most room for accommo-
dation of the AQ within the duplex. (2)-(5) Each of the four 
DNA bases: G, A, C and T were incorporated into the 
sequence. These DNA oligomers are identified as 
DNA579Z, where Z=X (Abasic), G, A, C, and T, respec-
tively. 
DNA: 5'-TCG-CTG-GAA-Z-AAG-GTA-GGA-3' (SEQ ID NO:l) 
DNA579Z 
PNA: H-Lys-Lys-TCC-TAC-CTT-Y-TTC-CAG-CGA-Gly-NH2 
(SEQ ID N0:2) 
PNA554: Y~Acetyl 
PNA579: Y~Ql 
PNA586: Y~Q2 
The PNA579/DNA579X hybrid melts with high cooperat-
ivity at Tm=61.4° C. (FIG. 12). There is no hysteresis in the 
transition indicative of rapid hybridisation kinetics as pre-
viously observed for full-length 1:1 PNA-DNA duplexes. 
The PNA586/DNA579X hybrid melts at 68.3° C., approxi-
PNA oligomers were calculated using the nearest neighbour 
values for DNA, with Adenine substituted for Q or R. 50 
(Because of the length of the PNA oligomers, the error 
introduced by this substitution will be negligible.) In a 
typical measurement, PNA was dissolved in water and the 
absorbance at 260 nm was measured after incubation for 5 
minutes at 75° C. in order to minimise secondary structure 55 mately seven degrees higher than for PNA579. The greater 
stabilization for PNA586 could be due to the increased in the PNA. (Extinction coefficients determined from room 
temperature absorbance measurements tend to be 5-10% 
lower than those measured at the higher temperature). DNA 
oligomers were purchased from Midland Certified Reagent 
Company. 
Example 8 
Formation of Stable PNA/DNA Hybrids: Thermal 
Denaturation Studies 
This example demonstrates the ability of PNAs containing 
an electron acceptor to hybridize with complementary DNA 
oligomers. 
flexibility which arises from the longer linker connecting the 
AQ to the PNA backbone. In both cases, the Tm is signifi-
cantly higher than when the PNA bears only an acetyl group 
60 at the central position, indicating that the AQ moiety stabi-
lizes the PNA/DNA hybrid (Table 1). 
Monitoring the Tm at 330 nm, where only the AQ unit 
absorbs light, reveals monophasic transitions for both PNN 
DNA hybrids (FIG. 12). The hyperchromicity observed for 
65 the PNA586/DNA579X hybrid is nearly twice as great as 
that for the PNA579/DNA579X hybrid, consistent with a 
structure in which the AQ unit is intercalated into the duplex 
6,117,973 
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and that insertion of the AQ is more favorable for the longer 
linker. 
TABLE 1 
Effect of AQ Linker Length on PNA/DNA Hybrid Stability 
[Duplex] 
PNA (µM) Wavelength( nm) Tm(° C) % Hypochromicity 
554 1.0 260 56.6 16.5 
579 1.0 260 61.4 13.5 
586 1.0 260 68.3 15.5 
32 
Photocleavage of the DNA strand within PNA-AQ/DNA 
hybrids was studied using radiolabelled DNA and polyacry-
lamide gel electrophoresis (PAGE). Synthetic DNA oligo-
mers were labelled at the 5'-0H terminus using [y-32P]-ATP 
5 and T4 polynucleotide kinase according to standard proce-
10 
dures. 5'-endlabelled oligomers were purified by 20% dena-
turing PAGE and precipitation. Samples were prepared for 
irradiation by mixing 5.0 µM each of PNA and unlabelled 
DNA as well as labelled DNA (2000-4000 cpm per sample) 
in 10 mM sodium phosphate buffer (pH=7.0). This ensures 
that there will be a slight excess of DNA over PNA, 
minimising contributions from unhybridised PNA. Samples 
The PNAs form stable hybrids with the DNA579Z oli-
gomers in which Z=G, A, C or T (Table 2). The resulting 15 
hybrids are only slightly less stable than the corresponding 
duplexes with Z=X. 
were heated to 85° C. for 5 min then allowed to cool to room 
temperature. In cases where the only difference in samples 
would be the irradiation time, a single sample was prepared 
by this procedure and irradiated, with aliquots removed at 
the desired times. 
TABLE 2 
Effect of Opposed Base on PNA/DNA Hybrid Stability (Tm given in ° C.) 20 
Irradiation was performed using a Rayonet photoreactor 
equipped with 8 lamps O•max=350 nm). Samples were placed 
in microcentrifuge tubes and suspended parallel to the lamps 
via a rotating sample holder. While most of the exciting light 
is either not incident on the tubes or scattered by them, the 
tubes are sufficiently transparent at 330 nm to permit pho-
tocleavage to proceed in reasonable times (less than one 
hour). 
Base PNA554 PNA579 PNA586 
x 56.6 61.4 68.3 
G 55.6 59.2 65.9 
A 57.3 59.7 66.6 
c 55.8 59.7 67.1 
T 56.8 59.5 67.4 
Effect of Single Mismatches 
PNA555 is analogous to PNA579 with the exception of 
replacing with G at position 7. Hybridisation of this PNA 
with its abasic DNA complement (DNA555X) yields a 
duplex which melts at 63.1 ° C. The 2° C. stabilisation 
relative to PNA579/DNA579X could reflect greater base 
stacking in the region of the C-7 (PNA)/G-32 (DNA) base 
pair. Hybridisation of PNA555 with DNA579 yields a 
duplex which possesses a G-G mismatch and melts at 53.4° 
C. Thus, a single mismatch depresses Tm by 8-10° C. 
Effect of PNA Orientation on Hybrid Stability 
The preferred orientation of PNNDNA duplexes is 
antiparallel, where the PNA N-termini are aligned with the 
DNA 3'-termini. If the PNA579 sequence is inverted, 
hybridization with DNA579 produces a duplex which melts 
at 49.9° C. Thus, parallel orientation of the PNA and DNA 
strands results in reduction of the Tm by ca. 11 ° C. 
These experiments demonstrate that the DNA recognition 
properties of the PNA(AQ) conjugates are completely analo-
gous to those ofunmodified PNAstrands. While the stability 
of the resulting duplexes are most likely lower than would 
be observed for a 19 base pair PNA-DNAhybrid (due to the 
lack of base-pairing at the central AQ position), the presence 
25 
For experiments involving methylene blue, PNA-DNA 
hybrids were prepared as described above, then methylene 
blue was added to give 10 or 20 µM concentration. Samples 
were irradiated for 15 min using the filtered (f.>600 nm) 
30 output of a 150 W Hg arc lamp. 
For experiments in which D2 0 was substituted for water, 
all of the components (PNA, DNA, buffer, methylene blue 
where desired) were mixed, then the water was evaporated 
under vacuum. 20 µl D2 0 was added to the samples and then 
35 removed by evaporation. This procedure was repeated, then 
the samples were finally dissolved in the appropriate amount 
of D2 0. An identical procedure was followed using H2 0 for 
control samples. 
After irradiation, the salt concentration was increased by 
40 addition of sodium acetate (pH=5.2) to 0.3 M, and magne-
sium chloride to 10 mM in a total volume of 50 µL. 100 µL 
cold ethanol was added and after vortexing, samples were 
placed on dry ice for 30 min. followed by centrifugation at 
12,000 g for 30 min. The supernatant was discarded and the 
45 pellet washed with 80% ethanol prior to drying. Samples 
were either then suspended in denaturing loading buffer or 
incubated with 100 µL piperidine (1 M) for 30 min at 90° C. 
After the piperidine was removed by vacuum evaporation, 
the DNA was dissolved in 20 µL water which was then 
50 evaporated. This procedure was performed once more and 
then the DNA was suspended in denaturing loading buffer. 
DNA fragments were ultimately separated on a 20% dena-
turing polyacrylamide gel and cleavage sites were visualised 
by autoradiography. 
of the AQ moiety stabilises the duplex by >4 ° C. relative to 55 
the case where both strands contain abasic residues at the 
Irradiation of a PNA579/DNA579X duplex with 350 nm 
light for one hour led to very little spontaneous degradation 
of the DNA. However, after piperidine treatment, strong 
cleavage is observed at several positions (FIG. 13, Lane 8). 
Cleavage is not observed for a PNA554/DNA579X hybrid, 
central position, indicative of a strong interaction (stacking) 
between the AQ and the duplex. 
Example 9 
Detection of Electron Transfer within PNA/DNA 
Hybrids by Photocleavage Assay 
This example describes the ability of the PNA containing an 
anthraquinone (AQ) to initiate photocleavage of the DNA 
strand within a hybrid duplex by photoinduced electron 
transfer. 
60 which lacks anAQ moiety (Lane 4). The main cleavage sites 
are the three GG steps as well as the abasic site at the center 
of the duplex. Previous work has shown that irradiation of 
DNA-intercalated AQ leads to piperidine-dependent cleav-
age with high selectivity at the 5 '-G of GG doublets. It has 
65 unambiguously been shown in the literature (Breslin, D. T. 
and Schuster, G. B. J. Am. Chem. Soc. 1996, 118, 
2311-2319) that this GG-selective cleavage of DNA is 
6,117,973 
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initiated by photoinduced electron transfer from the DNA 
bases to the excited state AQ. The similar selectivity 
observed in FIG. 13 suggests that the AQ reacts similarly 
with the PNAJDNA hybrid. 
For the two GG sites on the 3' end of the duplex, cleavage 5 
at the 5' G is favored over that at the 3' G. Thus, the two GG 
sites oriented in the 3' direction relative to the AQ exhibit the 
same 5'-dependent cleavage as observed in duplex DNA. 
However, cleavage at the GG step on the 5'-side of the AQ 
is distributed evenly between the two sites. The 5'-vs 10 
3'-distribution of cleavage at the GG step has been proposed 
to depend on the angle of rotation between the two guanines 
as they stack atop one another (Sugiyama, H. and Saito, I., 
J. Am. Chem. Soc. 1996, 118, 7063-7068). However, it is 
important to note that trapping requires not only a signifi- 15 
cantly lower oxidation potential at the GG site but also a 
chemical reaction to prevent the electron and hole from 
recombining. This step involves addition of either water or 
oxygen to the guanine radical cation, a process which will be 
influenced by the exposure of the base to solvent. It has been 20 
noted that the bases in PNA-DNA hybrids are closer to the 
exterior of the helix than in B-form DNA NMR (Erikkson, 
M.; Nielsen, P. E. Nature Struct. Biol. 1996, 3, 410-413) and 
x-ray diffraction data (Betts, L.; Josey, J. A; Veal, J. M.; 
Jordan, S. R. Science 1995, 270, 1838-1841) indicate that 25 
the degree of inter- and intrastrand stacking within PNA-
DNAhybrids is highly sequence dependent. Thus there is no 
reason to expect that the GG cleavage will exhibit the same 
5'-preference as observed in duplex DNA This is supported 
by the cleavage data on PNNDNAhybrids disclosed in this 30 
invention. 
34 
triplet state molecules. We tested for the involvement of 
singlet oxygen by comparing the cleavage efficiencies for 
PNAJDNA hybrid in the presence of D2 0 with H20. (The 
lifetime of singlet oxygen is increased nearly tenfold in the 
presence of D20, leading to significantly enhanced cleavage 
by singlet oxygen generators). There is no enhancement of 
cleavage for the sample irradiated in D20, arguing against a 
role for singlet oxygen in the mechanism. We also studied 
cleavage of the DNA strand in the PNNDNA hybrid using 
a known singlet oxygen generator, methylene blue. Irradia-
tion with visible light (f.>600 nm) results in selective 
cleavage at the guanine residues with a pattern which is 
similar to that of the AQ-sensitised cleavage. However, this 
chemistry is strongly enhanced when D2 0 is substituted for 
H 2 0. 
At first consideration, the similar cleavage patterns 
observed for direct irradiation of the AQ and for singlet 
oxygen generation by methylene blue would suggest that the 
quinone-mediated cleavage also involves singlet oxygen. 
However, the lack of inhibition by non-specific DNA dem-
onstrates that cleavage is not mediated by freely diffusing 
singlet oxygen. The only way that singlet oxygen could be 
responsible for the cleavage is if it is generated by the AQ 
at the central position of the duplex, then diffuses one-
dimensionally along one of the grooves in either direction 
until it reacts with a guanine. The different intensities 
observed for various Gs would then reflect access of the base 
to the singlet oxygen molecule. Such a process should 
exhibit a distance dependence, however, since the first GG 
step in the 3'-direction would be expected to be a barrier to 
cleavage at the distal GG step. The equal cleavage observed 
at these two sites is clearly inconsistent with such a mecha-
nism. Further evidence against a singlet oxygen dependent 
mechanism comes from the observation that anthraquinone-
Experiments were performed with PNA586/DNA579X 
which were analogous to those performed with PNA579. 
The results for the longer linker are similar to the shorter 
linker: After piperidine treatment, cleavage is observed at all 
three GG sites as well as at the abasic site (FIG. 13, Lane 
12). The 5'-G is clearly favored for the two sites which are 
on the 3'-side of the abasic site while the two Gs are cleaved 
approximately equally at the other GG site. One notable 
observation is that the cleavage efficiency for the longer 
linker connecting the AQ to the PNA backbone is signifi-
cantly lower than for the shorter linker. 
35 2-sulfonate, which is freely diffusing in solution, does not 
induce cleavage of the PNA-DNA hybrid. It is unlikely that 
the covalently linked AQ can generate singlet oxygen when 
the unbound AQ cannot, particularly in light of the strong 
phosphorescence quenching (see Example 10) within the 
It is clear that the cleavage is occurring at positions which 
are far from the AQ. In particular, the distal GG step in the 
3' direction is ca. 22 A away from the AQ within the hybrid 
(based on a rise of 3.6 A per base pair). Even if the AQ were 
able to adopt extrahelical conformations, the short linker 
connecting it with the backbone precludes direct reaction 
between the AQ and the remote G sites. We next investigated 
the possibility that the AQ was generating a freely diffusible 
species. If the PNA and DNA strands are annealed in the 
presence of a tenfold excess of unlabeled DNA579X the 
cleavage is completely eliminated. However, if the anneal-
ing is performed in the presence of an excess of unlabeled, 
non-complementary DNA, no effect on the cleavage is 
observed. This rules out the possible intermediacy of a freely 
diffusing cleavage agent. Additionally, if the excess unla-
beled DNA579X is added after annealing but prior to 
irradiation, minimal attenuation of the cleavage is observed. 
This indicates that the PNAJDNA hybrid is thermally stable 
throughout the irradiation time. These experiments demon-
strate that the cleavage arises from excitation of AQ moiety 
and that the damage is localised at the same duplex wherein 
the photon is absorbed. 
40 duplex. A further argument against singlet oxygen derived 
cleavage comes from densitometric analysis of the ratio of 
cleavage at the 5' and 3' guanine residues in the distal GG 
site toward the 3' end of the duplex. For the AQ-initiated 
cleavage, this ratio is 1.40, whereas for methylene blue it is 
45 0.69. If the same intermediate were responsible for the DNA 
damage, then the ratio of 5'/3' cleavage should be the same 
for AQ and methylene blue. 
In light of the preceding discussion, the only explanation 
for the observed cleavage is electron transfer in the PNN 
50 DNA duplex. TheAQ triplet is quenched by electron transfer 
from an adjacent base, resulting in the injection of a hole 
within the duplex. This hole can subsequently migrate 
through the helix until it is trapped at a GG site (see FIG. 5). 
Incorporation into the duplex of a "trap" site, i.e. a site with 
55 an even lower oxidation potential than GG, should signifi-
cantly alter the cleavage efficiency at the GG sites. The 
guanine oxidation product, 7,8-dihydro-8-oxoguanine 
(8-0xoG) was chosen as a potential trap site since its 
oxidation potential is estimated by Sheu and Foote to be ca. 
60 0.4 V lower than that of guanine (Sheu, C.; Foote, C. S. J. 
Am. Chem. Soc. 1995, 117, 6439-6442). DNAS79T(OxoG) 
is analogous to DNA579T except that G-13 is replaced by 
8-0xoG. This DNA was radiolabeled on the 5'-terminus 
Selective cleavage at G residues by photonucleases in 65 
duplex DNA is typically the result of either electron transfer 
chemistry or singlet oxygen, which can be generated by 
according to standard procedures, then hybridized with 
PNA579 and irradiated. After piperidine treatment, a sig-
nificant enhancement is observed in the cleavage at the 
8-0xoG position, while cleavage at the distal GG site is 
6,117,973 
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significantly suppressed relative to the case where a normal 
G is present at position 13. (See FIG. 14, compare lanes 8 
and 4). This observation is consistent with a model in which 
the excited state AQ accepts an electron from an adjacent 
base at the intercalation site, injecting a hole into the 5 
PNAJDNA helix. This hole migrates along the helix by a 
series of discrete electron transfers until it reaches a GG site 
where it can be trapped by reaction with water or oxygen. 
The (8-0xoG)G site is a more effective trap than is a normal 
GG site, inhibiting migration of the hole to the distal GG 10 
site. Significantly, cleavage at the GG site in the other 
direction is unaffected by the 8-0xoG. 
Example 10 
36 
denaturation and fluorescence spectroscopy. A similar 
approach has been reported by Tyagi and Kramer (Tyagi, S.; 
Kramer, F. R. Nature Biotechnol. 1996, 14, 303-308). In that 
strategy, a DNA hairpin was labelled with an energy donor 
and acceptor. Hybridization led to decreased energy transfer 
between the donor and acceptor. The use of PNA in the 
present invention rather than DNA is preferred because of 
the superior hybridization characteristics of PNA, namely 
the much higher affinity and ionic strength independence of 
the PNA-DNA recognition. The choice of electron transfer 
rather than energy transfer in the present invention arises 
from the fact that fewer restrictions are placed on the donor 
and acceptor moieties for photoinduced electron transfer 
chemistry. In particular, either the donor or acceptor can be 
Evidence for Photoinduced Electron Transfer from 
Low Temperature Phosphorescence Experiments 
15 irradiated and there is no requirement that the donor absorb 
light of shorter wavelength than the acceptor. 
This example uses phosphorescence spectroscopy to study 
the reaction of the excited state AQ with the PNAJDNA 
hybrid. 
20 Phosphorescence emission was measured as an indication 
of electron transfer from the bases of the hybrid to the 
photoexcitedAQ, since electron transfer quenches this emis-
sion. (The quantum yields for phosphorescence are suffi-
ciently low that the samples have to be prepared in a frozen 
25 glass matrix in order to be able to detect the phosphores-
cence. The matrix used was 30% ethylene glycol in 10 mM 
phosphate buffer, pH=7.0. Stable hybrids are formed even in 
the presence of the glycol as evidenced by a suppression of 
the Tm of less than 5° C.) Samples were prepared consisting 
30 
of AQC(2) (a water soluble AQ), or PNA-AQ alone or with 
complementary DNA. In each case, the concentration ofAQ 
(linked or unlinked to PNA) was 5.0 µM, as was the DNA 
concentration for the last sample. Samples were prepared in 
10 mM sodium phosphate buffer (pH=7.0) and 30% ethylene 
35 glycol, which is required in order to form a low-temperature 
glass. For PNAJDNAhybrids, samples were heated to 85° C. 
for 5 min then allowed to cool to room temperature prior to 
addition of ethylene glycol. Samples ( 400 µl) were added to 
NMR tubes, shaken to position the liquid at the bottom of the 
40 
tube, then frozen in liquid nitrogen. Phosphorescence spec-
tra were recorded over the spectral region of 400-600 nm 
with excitation at 330 nm. Slits were set at 5.0 mm on both 
monochromators to maximise the signal intensity. Spectra 
were plotted after subtraction of the baseline recorded with 
45 
a frozen glass lacking AQ and normalisation at 400 nm. 
Emission spectra were recorded for three cases: (i) water 
soluble AQ in the absence of PNA and DNA, (ii) single-
stranded PNA, and (iii) PNA-DNA hybrids. For PNA579, 
the phosphorescence is quenched by ca. 70% and >90% in 
50 
the single-strand and hybrid forms, respectively, relative to 
the free AQ. Meanwhile, for PNA586, the phosphorescence 
is quenched by >90% in both the single-stranded and hybrid 
forms. (Data for PNA586 are plotted in FIG. 15.) These 
results indicate that there is efficient photoinduced electron 
55 transfer from the bases to the AQ in the hybrid. Moreover, 
electron transfer is also quite efficient in the single-stranded 
form, indicating the AQ moiety is capable of reacting with 
the PNA bases as well as the DNA bases. 
PNA626 and PNA627 are shown below in their extended 
and folded conformations. PNA626 contains an acridine 
moiety (R2 ) which functions as a light absorber and electron 
donor plus an anthraquinone moiety (Q1 ) which functions as 
an electron acceptor. In the folded conformation, the acri-
dine and quinone will be placed in close proximity to one 
another, particularly if both are stacked within the helix, 
leading to efficient photoinduced electron transfer, which is 
detected by quenching of the acridine fluorescence. PNA627 
is analogous to PNA626 except it lacks the quinone accep-
tor. A thymine is included in place of the quinone, leading to 
a T-T mismatch in the folded conformation. 
PNA626: H-A-T-A-T-Q-T-T-G-G-C-T-G-A-T-C-C-A-R2-T-A-T-A-
T-Lys-Lys-NH2 (SEQ ID N0:3) 
PNA627: H-A-T-A-T-T-T-T-G-G-C-T-G-A-T-C-C-A-Ro-T-A-T-A-
T-Lys-Lys-NH2 (SEQ ID N0:4) 
(SEQ ID NO: 3) PNA626 
C-T 
A-T-A-T-Q-T-T-G-1 \ 
1 G 
T-A-T-A-T-R2-A-C-C\ I 
T-A 
(SEQ ID NO: 4) PNA627 
C-T 
A-T-A-T-T-T-T-G-1 \ 
G 
T-A-T-A-T-R2-A-C-C\ I 
T-A 
DNA Targets (single stranded, linear) 
626A: 5'-T-G-G-A-T-C-A-G-C-C-A-A-3' (SEQ ID N0:5) 
626B: 5'-T-G-G-A-T-C-A-G-C-C-T-A-3' (SEQ ID N0:6) 
626C: 5'-T-G-G-A-T-C-T-G-C-C-A-A-3' (SEQ ID N0:7) 
6260: 5'-A-T-A-T-A-T-T-G-G-A-T-C-A-G-C-C-A-A-T-A-T-A-T-3' 
(SEQ ID NO:S) 
626A is perfectly complementary to the 12 base sequence 
separating the quinone from the acridine. 626B and 626C 
Example 11 
DNA Recognition by PNA Hairpins 
This example describes the use of hybridization to inhibit 
electron transfer quenching, demonstrating the ability of 
PNAJDNA duplexes to act as "bioinsulators". 
60 will hybridize with the PNAs but with single base mis-
matches. The mismatch for 626B will be located near the 
end of the resulting duplex, yielding a 10 base pair segment, 
whereas the mismatch for 626C will be located near the 
center of the resulting duplex, yielding 6 and 5 base pair 
In this example, sequence specific recognition of ss DNA 
by PNA hairpins 626 and 627 is demonstrated by thermal 
65 segments. 626D will hybridize with the full length of the 
PNAs, placing thymines across from the acridine and 
quinone moieties. 
6,117,973 
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Thermal Denaturation Experiments 
Samples were prepared containing 2.5 µM PNAin 10 mM 
sodium phosphate buffer (pH=7.0) with and without 2.5 µM 
DNA626A Melting curves were recorded by monitoring the 
absorbance at 260 nm over the temperature range 25-90° C. 
38 
factor, indicated by the broad hairpin melting curves, is that 
the acridine and quinone likely have multiple conformations 
(e.g. Intercalated or extrahelical). The incomplete quenching 
could arise from a population of hairpins in which only one 
5 of the two chromophores is actually intercalated at the time 
of excitation. 
FIG. 16 shows the curves for melting of the PNAs in the 
absence of DNA The substantial hyperchromicity (>20%) is 
consistent with a folded hairpin structure rather than an 
extended linear conformation. The transition midpoint is 10 
approximately 55° C. for PNA627. Melting is more complex 
for PNA626 but the transition to the extended conformation 
occurs within the range 55-65° C. 
Effect of Hybridization 
In the presence of complementary DNA, the hairpin is 
disrupted and a PNNDNA hybrid is formed. In the hybrid, 
the acridine and anthraquinone are separated by 12 base 
pairs instead of being in contact in the hairpin. This results 
in a substantial increase in the fluorescence (compare 
samples 1 and 2). The increase is much greater for PNA626 FIG. 17 shows the curves for melting of the PNAs in the presence of DNA626A The fact that the two curves in this 
figure are significantly different from those in FIG. 1 dem-
onstrates that the PNA and DNA strands are interacting with 
one another. A clear transition is observed at ca. 76° C. for 
both PNAs. This transition is attributed to melting of the 
desired PNNDNA hybrids. 
Fluorescence Experiments 
15 
than for 627, indicating that most of the enhanced fluores-
cence results from retarded electron transfer rather than from 
the change in the environment of the acridine fluorophore 
due to hybridization with the DNA strand. Note that the 
20 
fluorescence is still greater for PNA627, suggesting that 
there is still some electron transfer quenching occurring over 
12 base pairs within the hybrid. 
Samples were prepared containing 1.0 µM PNAin 10 mM 
sodium phosphate buffer (pH=7.0) with and without 1.0 µM 
DNA Samples were heated to 90° C. for 5 min, then cooled 25 
to room temperature over a period of 90 minutes. Fluores-
cence emission spectra were recorded over the range 
430--600 nm with excitation at 417 nm. 2.5 mm slits, 1.0 nm 
increment and 0.5 sec integration time were used for data 
collection. After collection, spectra were integrated to give 30 
the data shown below. 
Effect of Single Base Mismatches 
A single mismatch near the end of the recognition site 
results in a 12% decrease in fluorescence enhancement while 
a mismatch near the center of the recognition site results in 
a 23% decrease in fluorescence enhancement. As expected, 
the central mismatch results in shorter (and, therefore, less 
stable) hybrid regions, leading to less fluorescence enhance-
ment. 
TABLE 3 
Effect of Hybridization on ET Quenching of Acridine Fluorescence 
Sample PNA DNA Raw Data Normalized Data* 
626 None 3.35 1.00 
2 626 626A 12.0 3.58 
3 626 626B 11.0 3.28 
4 626 626C 9.98 2.98 
5 626 626D 25.1 7.49 
627 None 12.1 1.00 
7 627 626A 16.5 1.37 
8 627 626B 16.4 1.36 
9 627 626C 15.2 1.26 
10 627 626D 32.3 2.67 
*Data for each PNA were normalized to the values for the samples lack-
ing DNA (1 and 6). 
Effect of Quinone in PNA Hairpin 
Comparing samples 1 and 6, the fluorescence is 3.6 times 
lower when the quinone is present, consistent with quench-
ing of the acridine fluorescence by electron transfer to the 
adjacent quinone. The lack of complete quenching is most 
likely due to the fact that the electron transfer reaction is not 
very favorable energetically and the lifetime of the acridine 
is probably fairly short (a few nanoseconds). An additional 
SEQUENCE LISTING 
(1) GENERAL INFORMATION: 
(iii) NUMBER OF SEQUENCES: 8 
35 
Effect of Full-Length Hybridization 
The largest enhancements results from hybridization with 
a full length DNA complement (DNA626D, see Samples 5 
and 10). This result emphasizes the sensitivity of the acri-
dine fluorescence quantum yield to its environment: the 
emission is significantly greater when the acridine is part of 
40 a duplex as opposed to in a single strand. (The results for 
PNA627 also indicate that the acridine fluorescence quan-
tum yield is greater for a PNA-DNA versus a PNA-PNA 
hybrid. The fluorescence increases by 2.67 in the presence of 
DNA) The combination of this effect with the relieved 
45 electron transfer results in the large enhancement of fluo-
rescence. 
Assessment 
The donor-acceptor PNA hairpins appear to work as 
50 designed and significant enhancements of fluorescence arise 
from hybridization with all four DNA oligomers. In each 
case, the fluorescence was enhanced 2.4-2.8 times more for 
PNA626 than for PNA627, demonstrating the importance of 
the electron acceptor in the system. The experiments were 
55 performed on samples containing 1 nanomole each of PNA 
and DNA target; this could easily be decreased by a factor 
of 10. 
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(2) INFORMATION FOR SEQ ID NO:l: 
(i) SEQUENCE CHARACTERISTICS: 
(A) LENGTH: 19 base pairs 
(B) TYPE: nucleic acid 
(C) STRANDEDNESS: single 
(D) TOPOLOGY: linear 
(ii) MOLECULE TYPE: DNA (genomic) 
(ix) FEATURE: 
(A) NAME/KEY: misc feature 
(B) LOCATION: 10 
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(D) OTHER INFORMATION: /note~ "Position 10 may be an 
abasic nucleic acid." 
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:l: 
TCGCTGGAAN AAGGTAGGA 
(2) INFORMATION FOR SEQ ID N0:2: 
(i) SEQUENCE CHARACTERISTICS: 
(A) LENGTH: 18 base pairs 
(B) TYPE: nucleic acid 
(C) STRANDEDNESS: single 
(D) TOPOLOGY: linear 
(ii) MOLECULE TYPE: other nucleic acid 
(A) DESCRIPTION: /desc ~ "Peptide Nucleic Acid" 
(ix) FEATURE: 
(A) NAME/KEY: misc feature 
(B) LOCATION: 9 .. 10 
19 
(D) OTHER INFORMATION: /note~ "Between position 9 and position 
10 there is eithe an acetyl, a 3,6-Diaza-
(N3-2-anthraguinoyl)-N6-boc-hexanoic acid, or a 
3,6-Diaza(N3-boc-aminoethyl)-4,7-dioxo-7 
-(2-anthraguinyl)-heptanoic acid. 
(ix) FEATURE: 
(A) NAME/KEY: misc feature 
(B) LOCATION: 
(D) OTHER INFORMATION: /note~ "Position 1 has an H-Lys-Lys 
substituent." 
(ix) FEATURE: 
(A) NAME/KEY: misc feature 
(B) LOCATION: 18 
(D) OTHER INFORMATION: /note~ "Pastian 18 has a Gly-NH2 
substituent." 
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:2: 
TCCTACCTTT TCCAGCGA 
(2) INFORMATION FOR SEQ ID N0:3: 
(i) SEQUENCE CHARACTERISTICS: 
(A) LENGTH: 21 base pairs 
(B) TYPE: nucleic acid 
(C) STRANDEDNESS: both 
(D) TOPOLOGY: both 
(ii) MOLECULE TYPE: other nucleic acid 
(A) DESCRIPTION: /desc ~ "Peptide Nucleic Acid" 
(ix) FEATURE: 
(A) NAME/KEY: misc feature 
(B) LOCATION: 
(D) OTHER INFORMATION: /note~ "Position 1 is either 
unsubstituted or has an H- substituent." 
(ix) FEATURE: 
(A) NAME/KEY: misc feature 
18 
40 
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-continued 
(B) LOCATION: 4 .. 5 
(D) OTHER INFORMATION: /note~ "Between positions 4 and 5 is an 
anthraguinone moiety." 
(ix) FEATURE: 
(A) NAME/KEY: misc feature 
(B) LOCATION: 16 .. 17 
(D) OTHER INFORMATION: /note~ "Between positions 16 and 17 is 
an acridine moiety." 
(ix) FEATURE: 
(A) NAME/KEY: misc feature 
(B) LOCATION: 21 
(D) OTHER INFORMATION: /note~ "Position 21 is either 
unsubstitued or has a Lys-Lys-NH2 substituent." 
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:3: 
ATATTTGGCT GATCCATATA T 
(2) INFORMATION FOR SEQ ID N0:4: 
(i) SEQUENCE CHARACTERISTICS: 
(A) LENGTH: 22 base pairs 
(B) TYPE: nucleic acid 
(C) STRANDEDNESS: both 
(D) TOPOLOGY: both 
(ii) MOLECULE TYPE: other nucleic acid 
(A) DESCRIPTION: /desc ~ "Peptide Nucleic Acid" 
(ix) FEATURE: 
(A) NAME/KEY: misc feature 
(B) LOCATION: 
(D) OTHER INFORMATION: /note~ "Position 1 is either 
unsubstituted or has an -H substituent." 
(ix) FEATURE: 
(A) NAME/KEY: misc feature 
(B) LOCATION: 17 .. 18 
(D) OTHER INFORMATION: /note~ "Between positions 17 and 18 
is an acridine moiety." 
(ix) FEATURE: 
(A) NAME/KEY: misc feature 
(B) LOCATION: 22 
(D) OTHER INFORMATION: /note~ "Position 22 is either 
unsubstituted or has a Lys-Lys-NH2 substituent." 
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:4: 
ATATTTTGGC TGATCCATAT AT 
(2) INFORMATION FOR SEQ ID NO:S: 
(i) SEQUENCE CHARACTERISTICS: 
(A) LENGTH: 12 base pairs 
(B) TYPE: nucleic acid 
(C) STRANDEDNESS: single 
(D) TOPOLOGY: linear 
(ii) MOLECULE TYPE: DNA (genomic) 
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:S: 
TGGATCAGCC AA 
(2) INFORMATION FOR SEQ ID N0:6: 
(i) SEQUENCE CHARACTERISTICS: 
(A) LENGTH: 12 base pairs 
(B) TYPE: nucleic acid 
(C) STRANDEDNESS: single 
(D) TOPOLOGY: linear 
(ii) MOLECULE TYPE: DNA (genomic) 
21 
22 
12 
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(xi) SEQUENCE DESCRIPTION: SEQ ID N0:6: 
TGGATCAGCC TA 
(2) INFORMATION FOR SEQ ID N0:7: 
(i) SEQUENCE CHARACTERISTICS: 
(A) LENGTH: 12 base pairs 
(B) TYPE: nucleic acid 
(C) STRANDEDNESS: single 
(D) TOPOLOGY: linear 
(ii) MOLECULE TYPE: DNA (genomic) 
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:7: 
TGGATCTGCC AA 
(2) INFORMATION FOR SEQ ID NO:S: 
(i) SEQUENCE CHARACTERISTICS: 
(A) LENGTH: 23 base pairs 
(B) TYPE: nucleic acid 
(C) STRANDEDNESS: single 
(D) TOPOLOGY: linear 
(ii) MOLECULE TYPE: DNA (genomic) 
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:S: 
ATATATTGGA TCAGCCAATA TAT 
What is claimed is: 
1. A molecule of formula VIiia, VIIlb or VIiie 
L 
I 
A 
I 
E........_ /B-......_ /F or 
J D 
L 
I 
A 
I 
E .......... /B-......_ /E or 
J D 
L 
I 
A 
I 
~/B-......_ /F 
J D 
wherein 
A is a group of formula I/A, l/B, l/C or l/D 
6,117,973 
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-continued 
35 
VIII a 
40 
VIIIb 
45 
VIIIc 
50 
55 
60 
12 
12 
23 
-continued 
Formula l/B 
-flj {'j~ c y c c-12 12 R r R s 
Formula l/C 
-flj {ljf IT C Y C N-C-12 12 R r R s 
Formula l/D 
-f'j {'j~ r C Y C C-N--12 12 R r R s 
wherein 
Xis selected from the group consisting of 0, S, Se, NR3 , 
CH2 and C( CH3) 2 ; 
Y is selected from the group consisting of a single bond, 
0, Sand NR4 ; 
each of p and q is independently 0--5; 
each of r and s is independently 0-5; 
Formula !/A 
each of R1 and R2 is independently selected from the 
group consisting of hydrogen, CcC4 alkyl which is 
unsubstituted or substituted by a substituent selected 
from the group consisting of hydroxy, C1-C4 alkoxy 
and CcC4 alkylthio, hydroxy, C1-C4 alkoxy, CcC4 
alkylthio, amino and halogen; and 
-H+1tl 65 R3 is selected from the group consisting of hydrogen, 
C1-C4 alkyl which is unsubstituted or substituted by a 
6,117,973 
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substituent selected from the group consisting of 
hydroxy, C1-C6 alkoxy and Ci-C6 alkylthio, hydroxy, 
C1-C6 alkoxy, Ci-C6 alkylthio and amino; 
Bis Nor CH; 
J is selected from the group consisting of (a) (CR6R7)y, 5 
wherein (1) R6 is hydrogen and R7 is a side chain of a 
naturally occurring a-amino acid, (2) R6 and R7 are 
each independently selected from the group consisting 
of hydrogen, Ci-C6 alkyl, aryl, aralkyl, heteroaryl, 
hydroxy, Ci-C6 alkoxy, Ci-C6 alkylthio, NR3R4 
10 
wherein R3 is as defined above and R4 is independently 
selected from the group consisting of hydrogen, C1-C4 
alkyl which is unsubstituted or substituted by a sub-
stituent selected from the group consisting of hydroxy, 
C1-C6 alkoxy and C1-C6 alkylthio, hydroxy, Ci-C6 
15 
alkoxy, C1-C6 alkylthio and amino, and SR5 wherein 
R5 is selected from the group consisting of hydrogen, 
hydroxy, C1-C6 alkoxy and Ci-C6 alkyl which is 
unsubstituted or substituted by C1-C6 alkylthio, or (3) 
R6 and R7 , taken together with the atoms to which they 20 
are attached, form an alicyclic or heterocyclic ring 
system; (b) CO; (c) CS; and (d) CNR3, wherein R3 is 
as defined above; 
Dis CR6R7 , wherein R6 and R7 are as defined above; 
Eis selected from the group consisting of COOH, CSOH, 
SOOH and S020H, or a protected and/or activated 
derivative thereof; 
25 
46 
-S03 - , G)-So2-, (k)-CN, (1) P03 2-, (m) Po2-, (n) 
-COOH, (o) -COR', (p) -COOR', (q) -CSR', (r) 
-CSOR', (s) -COO-, (t) -N=N-, (u) halogen, 
(v) -NHR', (w) N(R'R"), (x) hydrocarbyl wherein the 
hydrocarbyl is selected from the group consisting of (1) 
C1-C10 alkyl, (2) C1-C10 alkenyl, (3) C1-C10 alkynyl 
and (4) a single or fused aryl having 6-30 carbon 
atoms, wherein any of groups (1)-(4) are uninterrupted 
or interrupted by at least one heteroatom selected from 
the group consisting of -N-, -NH-, -S- and 
-0- and the hydrocarbyl is unsubstituted or substi-
tuted at least once by R1 , wherein R1 is as described 
above, (y) a heterocyclic aromatic or non-aromatic 
moiety containing at least one heteroatom each inde-
pendently selected from the group consisting of-N-, 
-NH-, -S- and -0- which is unsubstituted or 
substituted at least once by R1 , wherein R1 is as 
described above, and (z) a bond, wherein R' and R" are 
selected from the possible definitions of R1-R6 as 
described above, 
wherein at least one of the groups R1-R6 is modified such 
that the group is capable of binding to the linker, with 
the proviso that the group of formula Illa or Illb is a 
non-nucleobase moiety. 
3. The molecule of claim 2, wherein the heterocyclic 
Fis NHR3 or NPgaR3 wherein R3 is as defined above and 
Pga is an amino protecting group; and 
Lis a non-nucleobase electron donor or acceptor moiety 
which is capable of participating in the complete trans-
aromatic or non-aromatic moiety as Ri-R6 is selected from 
30 the group consisting of pyridyl, imidazolyl, pyradazinolyl, 
quinolyl, acridinolyl, pyrrolyl, furyl, thienyl, isoxazolyl, 
oxazolyl and thiazolyl. 
fer of an electron, 
wherein any amino group in A, B, J and D is unprotected 
or protected by an amino protecting group. 
2. The molecule of claim 1, wherein L is a group of 
formula Illa or Illb 
4. The molecule of claim 2, wherein the single or fused 
35 aryl having 6-30 carbon atoms as R1-R6 is selected from the 
group consisting of phenyl, naphthyl, biphenyl, tolyl and 
anthracenyl, or fused combinations of the group. 
Illa 
I!Ib 
wherein 
X, Y, Z, Q, Vand Ware each independently selected from 
the group consisting of C, N, S and 0 atoms, and X, Y, 
40 
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Z, Q, V and W are each independently connected by 60 
single or double bonds and at least one of X, Y, Z, Q, 
V and W, together with the moiety to which it is bound, 
may also be selected from the group consisting of 
-CO-, -SO- and -S02-; and 
Ri-R6 are each independently selected from the group 65 
consisting of (a) hydrogen, (b) oxygen, (c) hydroxy, (d) 
-OR', (e)-SH, (t)-SR', (g)-NH2, (h)-N02, (i) 
5. The molecule of claim 1, wherein Lis of formula IVa, 
IVb, lVc, lVd, or IVe, 
(R),~~O \~~{-(R) 
0 
(R\~~'/ 'n 0 
- N-(R) 
(R)1~ j m 0 
0 (R), 0 R-N~~' 
0 0 
!Va 
!Vb 
!Ve 
6,117,973 
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-continued 
!Vd 
5 
10 
!Ve 
15 
20 
0 
wherein R in each case is selected from the group con- 25 
sisting of (a) hydrogen, (b) oxygen, (c) hydroxy, (d) 
-OR', (e)-SH, (t)-SR', (g)-NH2, (h)-N02, (i) 
-So3-, G) -So2-, (k) -CN, (1) -Po/-, (M) 
-Po2-, (n)-COOH, (o) -COR', (p)-COOR', (q) 
-CSR', (r)-CSOR', (s)-COO-, (t)-N=N-, (u) 30 
halogen, (V) -NHR', (w) N(R'R"), (x) hydrocarbyl 
wherein the hydrocarbyl is selected from the group 
consisting of (1) C1-C10 alkyl, (2) CcC10 alkenyl, (3) 
C1-C10 alkynyl and ( 4) a single or fused aryl having 35 
6-30 carbon atoms, wherein any of groups (1)-(4) are 
uninterrupted or interrupted by at least one heteroatom 
selected from the group consisting of -N-, -NH-, 
-S- and -0- and the hydrocarbyl is unsubstituted 
or substituted at least once by R, wherein R is as 40 
described above, (y) a heterocyclic aromatic or non-
aromatic moiety containing at least one heteroatom 
each independently selected from the group consisting 
of -N-, -NH-, -S- and -0- which is unsub- 45 
stituted or substituted at least once by R, wherein R is 
as described above, and (z) a bond, wherein R' and R" 
are selected from the possible definitions of R as 
described above, 
50 
wherein at least one of the groups-R in each case is 
modified such that the group is capable of binding to 
the linker, 
n and m are each independently 0 or an integer from 1 to 
10, and 55 
k, r and 1 are each independently 0 or an integer from 1 
to 4. 
6. The molecule of claim 1, wherein L is of formula Va, 
Vb, Ve or Vd, 
60 
Va 
65 
48 
-continued 
Vb 
(R)k 
--c 0-R ;_-R-;_ R 
"=\ 
(R), 
Ve 
Vd 
N' 
I 
R 
wherein R in each case is selected from the group con-
sisting of (a) hydrogen, (b) oxygen, (c) hydroxy, (d) 
-OR', (e)-SH, (t)-SR', (g)-NH2, (h)-N02, (i) 
-S03-, G) -So2-, (k) -CN, (1) -Po/-, (m) 
-Po2-, (n)-COOH, (o)-COR', (p)-COOR', (q) 
-CSR', (r)-CSOR', (s)-COO-, (t)-N=N-, (u) 
halogen, (v) -NHR', (w) N(R'R"), (x) hydrocarbyl 
wherein the hydrocarbyl is selected from the group 
consisting of (1) C1-C10 alkyl, (2) CcC10 alkenyl, (3) 
C1-C10 alkynyl and ( 4) a single or fused aryl having 
6-30 carbon atoms, wherein any of groups (1)-(4) are 
uninterrupted or interrupted by at least one heteroatom 
selected from the group consisting of -N-, -NH-, 
-S- and-0- and the hydrocarbyl is unsubstituted 
or substituted at least once by R, wherein R is as 
described above, (y) a heterocyclic aromatic or non-
aromatic moiety containing at least one heteroatom 
each independently selected from the group consisting 
of -N-, -NH-, -S- and -0- which is unsub-
stituted or substituted at least once by R, wherein R is 
as described above, and (z) a bond, wherein R' and R" 
are selected from the possible definitions of R as 
described above, 
wherein at least one of the groups R in each case is 
modified such that the group is capable of binding to 
the linker, 
n and m are each independently 0 or an integer from 1 to 
10, and 
k, r and 1 are each independently 0 or an integer from 1 
to 4. 
6,117,973 
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7. The molecule of claim 1, wherein Lis of formula Via, 
Vlb or Vic, 
Via 
Vlb 
Vlc 
5 
10 
15 
20 
25 
30 
wherein R in each case is selected from the group con- 35 
sisting of (a) hydrogen, (b) oxygen, (c) hydroxy, (d) 
-OR', (e)-SH, (t)-SR', (g)-NH2 , (h)-N02 , (i) 
-So3 -, G) -So2-, (k) -CN, (1) -Po/-, (m) 
-Po2 -, (n)-COOH, (o) -COR', (p)-COOR', (q) 
-CSR', (r) -CSOR', (s) -Coo-, (t) -N=N-, (u) 40 
halogen, (v) -NHR', (w) N(R'R"), (x) hydrocarbyl 
wherein the hydrocarbyl is selected from the group 
consisting of (1) C1-C10 alkyl, (2) CcC10 alkenyl, (3) 
C1-C10 alkynyl and ( 4) a single or fused aryl having 45 6-30 carbon atoms, wherein any of groups (1)-(4) are 
uninterrupted or interrupted by at least one heteroatom 
selected from the group consisting of -N-, -NH-, 
-S- and -0- and the hydrocarbyl is unsubstituted 
or substituted at least once by R, wherein R is as 50 
described above, (y) a heterocyclic aromatic or non-
aromatic moiety containing at least one heteroatom 
each independently selected from the group consisting 
of -N-, -NH-, -S- and -0- which is unsub-
55 
stituted or substituted at least once by R, wherein R is 
as described above, and (z) a bond, wherein R' and R" 
are selected from the possible definitions of R as 
described above, 
wherein at least one of the groups R in each case is 60 
modified such that the group is capable of binding to 
the linker, 
n, m and o are each independently 0 or an integer from 1 
to 10, and 65 
k, r, 1, t and q are each independently 0 or an integer from 
1 to 4. 
50 
8. The molecule of claim 1, wherein Lis of formula Vlla, 
Vllb or Vlk, 
VII a 
Vllb 
Vile 
R 
(R)w(R)< ~ ~ '% 
7 ~ " 
f NH N 
' 
R R 
-N NH ~ Y~\ (R), (R)q 
R 
wherein R in each case is selected from the group con-
sisting of (a) hydrogen, (b) oxygen, (c) hydroxy, (d) 
-OR', (e)-SH, (t)-SR', (g)-NH2 , (h)-N02 , (i) 
-So3-, G) -so2-, (k) -CN, (I) -Po/-, (m) 
-Po2 -, (n)-COOH, (o)-COR', (p)-COOR', (q) 
-CSR', (r) -CSOR', (s) -Coo-, (t) -N=N-, (u) 
halogen, (v) -NHR', (w) N(R'R"), (x) hydrocarbyl 
wherein the hydrocarbyl is selected from the group 
consisting of (1) C1-C10 alkyl, (2) CcC10 alkenyl, (3) 
C1-C10 alkynyl and ( 4) a single or fused aryl having 
6-30 carbon atoms, wherein any of groups (1)-(4) are 
uninterrupted or interrupted by at least one heteroatom 
selected from the group consisting of -N-, -NH-, 
-S- and-0- and the hydrocarbyl is unsubstituted 
or substituted at least once by R, wherein R is as 
described above, (y) a heterocyclic aromatic or non-
aromatic moiety containing at least one heteroatom 
each independently selected from the group consisting 
of -N-, -NH-, -S- and -0- which is unsub-
stituted or substituted at least once by R, wherein R is 
as described above, and (z) a bond, wherein R' and R" 
are selected from the possible definitions of R as 
described above, 
wherein at least one of the groups R in each case is 
modified such that the group is capable of binding to 
the linker, 
n, m, o and p are each independently 0 or an integer from 
1to10, and 
k, r, 1 and q are each independently 0 or an integer from 
1 to 4. 
6,117,973 
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9. The molecule of claim 1, wherein the molecule is of 
formula IX, 
o) 
X'OOCYN~ 
NHPga 
R7 
IX 
5 
10 
52 
wherein 
X' is a carboxylic acid protecting group or hydrogen; 
R7 is hydrogen or a side chain of a naturally occurring 
a-amino acid, or an amino-protected and/or terminal 
activated derivative thereof; and 
Land Pga are as defined above. 
* * * * * 
